TEVA CANADA LIMITED v. NOVARTIS AG
Summary of T-2021-10
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Intellectual Property - Others [Actions]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| NOVARTIS AG | ||
| TEVA CANADA LIMITED | Heenan Blaikie LLP | STAINSBY, JONATHAN |
| Name | Number |
|---|---|
| 2093203 |
Patented Medicine: Imatinib (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Teva Canada Limited v. Novartis AG 2013 FC 141 | Feb 19, 2013 | Novartis AG (Novartis) is the recorded owner of Canadian Patent No. 2,093,203 (the '203 Patent), a patent applied for on April 1, 1993, granted to Novartis on November 26, 2002, and which will expire on April 1, 2013. Imatinib and its salt, imatinib mesylate, are compounds included in the '203 Patent. Teva Canada Limited (Teva) wishes to sell a generic version of imatinib. On December 3, 2010, Teva commenced an action against Novartis, seeking a declaration under s. 60(1) of the Patent Act that certain of the claims of the '203 Patent are invalid. |
| Teva Canada Limited v. Novartis AG 2012 FC 787 | Jun 19, 2012 | [Note: This decision is from 2012 but only recently published online.] In the context of Teva’s action for impeachment of Canadian Patent 2,093,203 covering the drug imatinib, commercialized by Novartis under the brand name GLEEVEC, Teva brings a motion to amend its statement of claim. ... The Federal Court of Appeal’s decision in Apotex v Bristol-Myers Squibb Co. et al., 2011 FCA 34, emphasizes that when faced with a motion to amend, the Court “has the duty to consider all relevant factors” (paragraph 5). The relevant factors are not confined to whether the proposed amendments constitute a radical change to the pleadings and will result in an injustice to the other side that cannot be compensated in costs. Notably, and as per the test in Canderel Ltd. v Canada, [1994] 1 FC 3, the question of whether the amendments should be allowed “for the purpose of determining the real question in controversy” and “would serve the interest of justice” must be addressed, and requires consideration of all of the circumstances of the case (see paragraphs 14, 33 and 34 of Apotex v Bristol Myers Squibb, supra). |
Appeals
The following appeals were taken from decision on this proceeding: [List of appeals is based on automated analysis and should not be relied upon.]
- A-100-13 is an appeal from 2013 FC 141
Docket Summary (Google Translate to English)
(295) 2016-03-10 - OttawaCertified French language Translation of Order rendered on 12-AUG-2011 by Mireille Tabib, Prothonotary filed on 10-MAR-2016 pursuant to s. 20 of the Official Languages Act. entered in J. & O. Book, volume 1295 page(s) 209 - 219
Acknowledgment of Receipt received from Plaintiff with respect to Cheque No. 2752-23505068-1 in the amount of $31187.40 placed on file on 08-MAR-2016
Letter sent by Registry on 07-MAR-2016 to Plaintiff Plaintiff's counsel (Mr. Jonathan Stainsby), Aitken Klee LLP enclosing Payment out of Court, Cheque No: 2752-23505068-1 in the amount of $31187.40, payable to Aitken Klee LLP in trust. As per counsel request the cheque was sent to Ottawa. Copy placed on file.
Letter sent by Registry on 22-FEB-2016 to the Financial Administration re: Payment out of Court pursuant to the Order of Prothonotary Tabib dated February 12, 2016. Copy placed on file.
Acknowledgment of Receipt received from all parties by email with respect to Doc. 294 placed on file on 22-FEB-2016
Order dated 12-FEB-2016 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 09-FEB-2016 Result: granted 1. The sum of $30,000.00 desposited on December 23, 2010, by the Plaintiff into the Federal Court Registry, plus any interest accumulated thereon, be paid out of Court to Aitken Klee LLP, in trust for the Plaintiff. Filed on 16-FEB-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1293 page(s) 22 - 22 Interlocutory Decision
Letter from Plaintiff dated 09-FEB-2016 seeking leave of the Court not to prepare a formal motion to obtain an Order for payment out, on consent. (draft order and other attachments enclosed) received on 09-FEB-2016
Covering letter from Plaintiff dated 02-FEB-2016 concerning Doc. No. 292 placed on file on 02-FEB-2016
Solicitor's certificate of service on behalf of Jonathan Stainsby confirming service of Doc. 292 upon Defendant by telecopier on 02-FEB-2016 filed on 02-FEB-2016
Notice of change of solicitor on behalf of Plaintiff filed on 02-FEB-2016
Acknowledgment of Receipt received from 2 counsel for the parties by fax on 8-JAN-2016 with respect to the Corrections (ID 612) of 22-JAN-2016 to page 1 of the Order of Tabib, P. dated 12-AUG-2011 (doc. # 79). placed on file on 22-JAN-2016
Letter sent by Registry on 22-JAN-2016 to 2 counsel for the parties by fax on 8-JAN-2016, enclosing a copy of the Corrections to page 1 on 22-JAN-2016 of the Order of Tabib, P., originally dated 12-AUG-2011 (doc. # 79). Copy placed on file.
CORRECTION TO ORDER of Tabib, P., dated 12-AUG-2011, corrected on 22-JAN-2016 at page 1. Copy sent to 2 counsel for the parties by fax on 22-JUN-2016. placed on file on 22-JAN-2016
Acknowledgment of Receipt received from 2 counsel for the parties by fax on 8-JAN-2016 with respect to Corrections (ID 609) of 7-JAN-2016 to the Order of Tabib, P. (doc. # 79) dated 12-AUG-2011. placed on file on 08-JAN-2016
Letter sent by Registry on 08-JAN-2016 to 2 counsel for the parties by fax on 8-JAN-2016, enclosing copy of Corrections of 7-JAN-2016 to pages 1, 4 + 7 of the Order of Tabib, P. dated 12-AUG-2011 (doc. # 79). Copy placed on file.
Corrections on 7-JAN-2016 to the Order of Tabib, P. dated 12-AUG-2011, corrections to pages 1, 4 and 7, received in the Registry on 8-JAN-2016. Faxed to 2 counsel for the parties on 8-JAN-2016 at 12:45 p.m. placed on file on 08-JAN-2016
Certified French language Translation of Reasons for Order and Order rendered on 19-JUN-2014 by Mireille Tabib, Prothonotary filed on 01-AUG-2014 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1238 page(s) 494 - 495 and copy placed on file.
Certified French language Translation of Public Judgment rendered on 19-FEB-2013 by The Honourable Madam Justice Snider filed on 13-JUN-2013 pursuant to s. 20 of the Official Languages Act. entered in J. & O. Book, volume 1196 page(s) 108 - 109
Copy of the certified French language translation of Publics Reasons of Judgment rendered on 19-FEB-2013 by The Honourable Madam Justice Snider placed on file on 13-JUN-2013 Original filed on Court File No. T-833-11
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order of the Court (Snider, J.) dated May 10, 2013. placed on file on 10-MAY-2013
Order dated 10-MAY-2013 rendered by The Honourable Madam Justice Snider Matter considered without personal appearance The Court's decision is with regard to Order dated 18-FEB-2013 Result: "THIS COURT ORDERS that costs are awarded to Novartis in accordance with the following: (Please see attached order). Filed on 10-MAY-2013 copies sent to parties entered in J. & O. Book, volume 1192 page(s) 401 - 412 Interlocutory Decision
Communication to the Court from the Registry dated 30-APR-2013 re: Submissions on Costs (re: Order of February 18, 2013)
Affidavit of service of Daniel Cappe sworn on 24-APR-2013 on behalf of Plaintiff confirming service of Doc. No. 287 upon Defendant by email on 24-APR-2013 filed on 24-APR-2013
Reply Submissions on behalf of plaintiffs Apotex Inc. and Teva Canada (jointly) in response to the opposing submissions doc. No. 285 to the Motion in writing Filed on 24-APR-2013
Solicitor's certificate of service on behalf of Alex Gloor confirming service of Defendant's Responding Submissions on Costs (doc 285) upon Plaintiff by email and courier on 24-APR-2013 filed on 24-APR-2013
Written Submissions in Response on behalf of Defendant concerning costs filed on 24-APR-2013
Solicitor's certificate of service on behalf of Marc Richard confirming service of the Costs Submissions upon Plaintiff (Teva Canada Limited) by email, on consent and courier on 09-APR-2013 confirming service the Costs Submissions upon Plaintiff (Apotex Inc) by email, on consent, and courier on 09-APR-2013 filed on 09-APR-2013
Written Submissions on behalf of Defendant concerning Costs (Pursuant to the Reasons for Judgment of Snider, J. dated 8-feb-13) filed on 09-APR-2013
Joint Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 09-APR-2013
Solicitor's certificate of service on behalf of Andrew McINtyre confirming service of Doc. NO. 281 and Book of Authorities upon Defendant by overnight courier on 09-APR-2013 filed on 09-APR-2013
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 09-APR-2013
Written Submissions on behalf of Plaintiff concerning costs filed on 09-APR-2013
MEMORANDUM to CASE MANAGEMENT JUDGE, Tabib, P., from Cynthia Leaver, Registry Assistant, Actions Section, Ottawa Registry, enclosing copy of Notice of Appeal in Federal Court of Appeal file A-100-13, appealing the Judgment of Snider, J., dated 8-FEB-2013. Sent by internal mail on 19-MAR-2013. placed on file on 19-MAR-2013
Copy of Notice of Appeal (Appeal Court File No. A-100-13 ) appealing Judgment of Snider, J., dated 8-FEB-2013 filed in the Court of Appeal on 11-MAR-2013 on behalf of Plaintiff placed on file on 19-MAR-2013
Book of redactions (3 volumes, transcripts and trial exhibits) on behalf of Novartis AG received on 08-JAN-2013
Redacted transcript of hearing from 3-OCT-2012 (vol. 7) received on 19-FEB-2013
Redacted transcript of hearing from 2-OCT-2012 (vol. 6) received on 19-FEB-2013
redacted transcipt of hearing of 25-SEP-2012 (vol. 2) received on 19-FEB-2013
Acknowledgment of Receipt received from all parties with respect to Direction, Public Judgment and Public Reasons and Order dated Feb. 19, 2013 placed on file on 19-FEB-2013
Payment in the amount of $1975.00 (AVR # 1415) on behalf the Defendant received on 27-FEB-2013
Memorandum to file from Benoit Labelle dated 21-FEB-2013 re: Forwarding final decisions to the CMJ, Prothonotary Tabib. placed on file.
Reasons for Judgment (Public) dated 13-FEB-2013 rendered by The Honourable Madam Justice Snider The Court's decision is with regard to Trial of the matter Filed on 19-FEB-2013 Same reasons also filed in T-833-11
Public Judgment dated 19-FEB-2013 rendered by The Honourable Madam Justice Snider Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: Subject to paragraph 2 of this Judgment, the claims of Teva Canada Limited are dismissed... Filed on 19-FEB-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1184 page(s) 349 - 350 Final Decision
Written directions received from the Court: The Honourable Madam Justice Snider dated 19-FEB-2013 directing that Reference is made to the Direction of February 8, 2013, wherein I directed that the Reasons for Judgment, issued jointly, and the Judgments in T-2021-10 and T-833-11, issued separately, were to be treated as confidential and maintained separate from the public record. On February 14, 2013 and February 15, 2013, in separate letters, counsel for Novartis AG and Novartis Pharmaceuticals Canada Inc. and counsel for Teva Canada Limited advised the Court that there were no portions of the Reasons for Judgment and the Judgments that should be redacted. Counsel for Apotex Inc. made submissions by letter to the Court dated February 15, 2013 requesting certain redactions be made. I accept Apotex' requested redactions and direct that they be incorporated into the Public Reasons for Judgment (and the Judgment issued in T-833-11) and the Court directs that the Public Reasons for Judgment and the Judgment issued in T-833-11 with the redactions and the Judgment issued in T-2021-10 (unredacted) are now to be released and form part of the public record. placed on file on 19-FEB-2013
Order dated 19-FEB-2013 rendered by The Honourable Madam Justice Snider Matter considered without personal appearance The Court's decision is with regard to Letter from Apotex dated 15-FEB-2013 Result: This Court orders that the letter is to be treated as confidential. Filed on 19-FEB-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1184 page(s) 336 - 338 Interlocutory Decision
Letter from Apotex Inc. (confidential) dated 15-FEB-2013 Further to the Direction of Justice Snider dated February 8, 2013, Apotex requests that certain portions of the Reasons for Judgment and Judgments in the above-noted proceedings be treated as confidential and thus redacted from the public version of the Reasons for Judgment and Judgments. *** Scanned to Snider, J. *** received on 15-FEB-2013
Payment of Court fees (ARV # 1413) in the amount of $987.50 placed on file on 14-FEB-2013
Acknowledgment of Receipt received from all parties with respect to Direction, Confidential Judgment and Confidential Reasons for Judgment placed on file on 11-FEB-2013
****** REMOVED ****** Acknowledgment of Receipt received from all parties with respect to the Direction, Confidential Judgment and Confidential Reasons for Judgment placed on file on 11-FEB-2013
Payment of Court fees (ARV # 1414) in the amount of $987.50 received on 11-FEB-2013
Reasons for for Judgment - Confidential dated 08-FEB-2013 rendered by The Honourable Madam Justice Snider The Court's decision is with regard to Trial of the matter Filed on 08-FEB-2013
Confidential Judgment dated 08-FEB-2013 rendered by The Honourable Madam Justice Snider Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: Confidential Filed on 08-FEB-2013 entered in J. & O. Book, volume 1183 page(s) 247 - 248 Final Decision
Written directions received from the Court: The Honourable Madam Justice Snider dated 08-FEB-2013 directing that the Confidential Reasons for Judgment of the Court dated February 8, 2013 and the Confidential Judgment of the Court dated February 8, 2013, in respect of the hearing of this matter in Toronto, may contain information that is confidential and also subject to the Amended Protective Order dated December 13, 2011 issued in both of these proceedings... placed on file on 08-FEB-2013
Acknowledgment of Receipt received from Mr. Brodkin for Apotex, Mr. Stainsby for Teva and Mr. Creber for Novartis with respect to doc. no. 275, by email. placed on file on 01-FEB-2013
Confidentiality Order dated 01-FEB-2013 rendered by The Honourable Madam Justice Snider Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 10-DEC-2012 Result: THIS COURT ORDERS that: 1. the documents and transcripts described in the attached Appendix A are to be treated as confidential; and 2. all other documents and exhibits are to be unsealed and no longer treated as confidential. Filed on 01-FEB-2013 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1182 page(s) 332 - 336 Interlocutory Decision
Request for payment of Court fees (ARV # 1415) in the amount of $1,975.00 placed on file on 29-JAN-2013
Request for payment of Court fees (ARV # 1414) in the amount of $987.50 placed on file on 29-JAN-2013
Request for payment of Court fees (ARV # 1413) in the amount of $987.50 placed on file on 29-JAN-2013
Letter from Plaintiff dated 03-JAN-2013 in response to direction dated 20-DEC-2012 of the Court received on 03-JAN-2013
Letter from Heenan Blaikie LLP for the Defendant dated 10-DEC-2012 indicating items that are to be marked confidential from the trial of this matter. received on 10-DEC-2012
transcript of hearing at trial (vol. 1) received on 26-SEP-2012
(CONFIDENTIAL) transcript of hearing at trial (vol. 2B) received on 26-SEP-2012
transcript of hearing at trial (vol. 2A) received on 26-SEP-2012
transcript of hearing at trial (vol. 3) received on 28-SEP-2012
transcript of hearing at trial (vol. 4) received on 01-OCT-2012
transcript of hearing at trial (vol. 5) received on 02-OCT-2012
(CONFIDENTIAL) transcript of hearing at trial (vol. 6) received on 03-OCT-2012
(CONFIDENTIAL) transcript of hearing at trial (vol. 7) received on 04-OCT-2012
transcript of hearing at trial (vol. 8) received on 10-OCT-2012
transcript of hearing at trial (vol. 9) received on 11-OCT-2012
(CONFIDENTIAL) transcript of hearing at trial (vol. 10) received on 12-OCT-2012
transcript of hearing at trial (vol. 11) received on 15-OCT-2012
transcript of hearing at trial (vol. 12) received on 16-OCT-2012
transcript of hearing at trial (vol. 13) received on 17-OCT-2012
transcipt of hearing at trial (vol. 14) received on 18-OCT-2012
(CONFIDENTIAL) transcript of hearing at trial (vol. 15) received on 07-NOV-2012
transcript of hearing at trial (vol 16) received on 08-NOV-2012
transcript of hearing at trial (vol. 17) received on 09-NOV-2012
transcript of hearing at trial (vol. 18) received on 12-NOV-2012
Letter from Defendant dated 13-DEC-2012 indicating items that are to be marked confidential from the trial of this matter received on 13-DEC-2012
Letter from Plaintiff dated 10-DEC-2012 indicating items that are to be marked confidential from the trial of this matter received on 10-DEC-2012
Letter from Defendant dated 20-DEC-2012 in response to the direction of the court dated 20-DEC-2012 received on 20-DEC-2012
Letter from Plaintiff dated 20-DEC-2012 Teva accepts the content of the direction dated 20-DEC-2012 and agrees that the documents listed therein are not confidential. Teva will file a public version of those documents. However, since those documents are included in both trial exhibit 26 and 27, Teva proposes that it file a public version of trial exhibit 27 only. received on 20-DEC-2012
Written directions received from the Court: The Honourable Madam Justice Snider dated 20-DEC-2012 directing that "I have received letters from counsel for Apotex, Teva and Novartis requesting that certain information consisting of documents and transcript extracts contained in the record of the Court files be designated confidential... placed on file on 20-DEC-2012
****** CANCELLED ****** Letter from Mr. Yoon Kang of Smart and Biggar dated 14-DEC-2012 with the Consent of Ranbaxy they are requesting a brief teleconference with Justice O'Keefe regarding the hearing on September 10, 11 and 12, 2012. They indicated their availabilities for December 18 and 19, 2012. Scanned to Justice O'Keefe's office. received on 14-DEC-2012
****** CANCELLED ****** Court Reporter Invoice from ASAP for Transcript of Hearing for matter heard in Ottawa on November 16, 2012. (#18965) received on 30-NOV-2012
Transcript of (volume 19) hearing held at Ottawa on November 16th, 2012 received on 28-NOV-2012 Sent directly to presiding Judge 163 pages (including covering pages).
Court Reporter Invoice #18776 (sitting/trans6,7,8,9-Nov-12) from ASAP received on 21-NOV-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc. 273 upon Plaintiff by telecopier on 14-NOV-2012 filed on 15-NOV-2012
(Confidential) Submissions of Novartis AG (re: SCC decision) filed on 15-NOV-2012
Book of Authorities of Novartis (Volume 5) consisting of 1 volume(s) on behalf of Defendant received on 16-NOV-2012
Document entitled "Sufficient Description" on behalf of the Defendant received at hearing on 16-NOV-2012
Defendant (Confidential) Day Book of Novartis AG (S.C.C. Teva v. Pfizer) received at hearing on 16-NOV-2012
Covering letter from Plaintiff dated 15-NOV-2012 concerning Doc. Nos. 271 272 placed on file on 15-NOV-2012
Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of Doc.271 and Plaintiff's Compendium of Evidence and Authorities upon Plaintiff by personal service on 15-NOV-2012 filed on 15-NOV-2012
Plaintiffs' Compendium of Evidence and Authorities (Confidential) received on 15-NOV-2012
Plaintiff's Outline of Argument on Insufficiency (Confidential) filed on 15-NOV-2012
Ottawa 16-NOV-2012 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Special Case To hear arguments from the parties as to the ramifications of the recent decision of the Supreme Court of Canada (Pfizer v. Teva Canada) on this matter. Result of Hearing: Matter reserved held in Court Senior Usher: André Deslauriers Duration per day: 16-NOV-2012 from 09:30 to 13:10 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Benoit Labelle Total Duration: 3h40min Appearances: Mr. Andrew Brodkin, Mr. Dino Clarizio, Mr. Daniel Cappe (416) 979-2211 representing Plaintiff (Apotex) Mr. Jonathan Stainsby (416) 360-6336 representing Plaintiff (Teva) Mr. Anthony Creber, Mr. John Norman, Ms. Jennifer Wilkie, Ms. Isabel Raasch (613)786-0140 representing Defendant Court Reporter: Nancy Grindley (ASAP Reporting Services Inc.) (613) 564-7756 16-NOV-2012 Transcript requested (on an expedited basis) Comments: Documents submitted by the Defendant: Sufficent Description dated Nov. 13, 2012; Day Book (S.C.C decision Teva v. Pfizer); Book of Authorities Matter heard with T-833-11 (Minutes of hearing on T-2021-10 only) Minutes of Hearing entered in Vol. 871 page(s) 75 - 80 Abstract of Hearing placed on file
Letter from ASAP Reporting Services Inc. dated 13-NOV-2012 re: Confirming the service of a Court Reporter for the Hearing in Ottawa on November 16, 2012. received on 13-NOV-2012
Letter sent by Registry on 13-NOV-2012 to ASAP Reporting Services Inc. to request to the service of a Court Reporter for the hearing in Ottawa on Nov. 16, 2012. Copy placed on file.
Oral directions received from the Court: The Honourable Madam Justice Snider dated 08-NOV-2012 directing that respecting the recent SCC decision in Pfizer, the court will hear submissions for one-half day on 16-NOV-2012 an how the decision will impact the matter at bar placed on file on 08-NOV-2012
Letter from the Respondent, Novartis AG and Pharmaceuticals dated 14-NOV-2012 providing submission regarding the argument on insufficiency. Scanned to Justice Snider. received on 15-NOV-2012
Letter from the Plaintiffs, Teva and Apotex dated 14-NOV-2012 providing submissions regarding the Plaintiffs' Outline of Argument on Insufficiency. Scanned to Justice Snider. received on 15-NOV-2012
Toronto 24-SEP-2012 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial in this action Result of Hearing: Matter reserved held in Court Senior Usher: Noel Nation 24-SEP-2012 Noel Nation 25-SEP-2012 Noel Nation 27-SEP-2012 Noel Nation 28-SEP-2012 John Grisé 01-OCT-2012 John Grisé 02-OCT-2012 John Grisé 03-OCT-2012 Greg Nevin 09-OCT-2012 Greg Nevin 10-OCT-2012 Greg Nevin 11-OCT-2012 Greg Nevin 12-OCT-2012 John Grisé 15-OCT-2012 Noel Nation 16-OCT-2012 John Grisé 17-OCT-2012 Sybil Mirosolin 06-NOV-2012 Sybil Mirosolin 07-NOV-2012 Sybil Mirosolin 08-NOV-2012 Sybil Mirosolin 09-NOV-2012 Duration per day: 24-SEP-2012 from 10:00 to 04:37 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 25-SEP-2012 from 09:03 to 02:03 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 27-SEP-2012 from 09:31 to 04:38 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 28-SEP-2012 from 09:01 to 04:04 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 01-OCT-2012 from 09:32 to 03:46 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 02-OCT-2012 from 09:32 to 04:34 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 03-OCT-2012 from 09:34 to 04:32 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 09-OCT-2012 from 09:32 to 04:32 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 10-OCT-2012 from 09:32 to 04:27 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 11-OCT-2012 from 09:33 to 04:30 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 12-OCT-2012 from 09:01 to 12:02 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 15-OCT-2012 from 09:32 to 04:34 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 16-OCT-2012 from 09:32 to 04:22 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 17-OCT-2012 from 09:30 to 12:30 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 06-NOV-2012 from 09:30 to 04:28 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 07-NOV-2012 from 09:30 to 04:29 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 08-NOV-2012 from 08:57 to 04:14 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 09-NOV-2012 from 09:01 to 02:55 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz Total Duration: 18d Appearances: Andrew Brodkin 416-979-2211 representing plaintiff (Apotex Inc.) Daniel Cappe 416-979-2211 representing plaintiff (APotex Inc.) Dino Clarizio 416-979-2211 representing plaintiff (Apotex Inc.) David Scrimger 416-979-2211 representing plaintiff (Apotex Inc.) Nando DeLuca 416-979-2211 representing plaintiff (Apotex Inc.) Michel Anderson 416-979-2211 representing plaintiff (Apotex Inc.) Jonathan Stainsby 416-360-6336 representing plaintiff (Teva Canada Ltd.) Andrew McIntyre 416-360-6336 representing plaintiff (Teva Canada Ltd.) Andrew Skodyn 416-360-6336 representing plaintiff (Teva Canada Ltd.) Lesley Caswell 416-360-6336 representing plaintiff (Teva Canada Ltd.) Anthony Creber 613-233-1781 representing Defendant Isabel Raasch 613-233-1781 representing Defendant John Norman 613-233-1781 representing Defendant Jennifer Wilkie 613-233-1781 representing Defendant Marc Richard 613-233-1781 representing Defendant Exhibits filed at hearing: 1-78 Witness(es) on behalf of Plaintiff Bernard Sherman, Chairman, Apotex Inc. 150 Signet Drive, Weston, ONT on behalf of Plaintiff Anne Bowes (Director, Office of Submissions and Intellectual Property) 48 Shannondoe Crescent, Ottawa, ONT on behalf of Plaintiff Dr. Lars Ronnstrand (Professor of Experimental Chemistry, Lund University) SE-205 U2, Malmo, Sweeden on behalf of Plaintiff Dr. Clayton Heathcock (Emeritus Professor, UC Berkeley) 5235 Alhambra Valley Road
Reply compendium submitted (CONFIDENTIAL) submitted on behalf of Teva and Apotex received at hearing on 09-NOV-2012
Compendium of Closing Arguments - Evidence submitted by Novartis AG (CONFIDENTIAL) received at hearing on 09-NOV-2012
Day book of evidence and authorities (5 volumes) (CONFIDENTIAL) on behalf of Novartis AG received at hearing on 07-NOV-2012
Reply to Novartis' legal assertions submitted on behalf of the plaintiffs Teva Canada and Apotex Inc. received at hearing on 07-NOV-2012
Reply to Novartis's Factual assertions (CONFIDENTIAL) submitted on behalf of the plaintiffs Teva Canada and Apotex Inc. received at hearing on 07-NOV-2012
Book of authorities (re: invalidity) consisting of 3 volume(s) on behalf of Plaintiff received on 05-NOV-2012
Outline of Argument (re: invalidity) submitted by Teva Canada LTd. filed on 02-NOV-2012
Affidavit of service of Thilo Kierdorf sworn on 05-NOV-2012 on behalf of Defendant confirming service of Books of AUthorities upon Goodmans by personal service on 05-NOV-2012 filed on 05-NOV-2012
Affidavit of service of THilo Kierdorf sworn on 05-NOV-2012 on behalf of Defendant (Novartis) confirming service of Defendant's authorities upon Heenan Blaikie by personal service on 05-NOV-2012 filed on 05-NOV-2012
Book of Authorities consisting of 3 volume(s) on behalf of Defendant (Novartis) **3 VOLUMES LABELLED: VOL 2, VOL 3, VOL 4** received on 05-NOV-2012
Solicitor's certificate of service on behalf of John Norman confirming service of doc. 266 upon all parties by electronically, on consent on 02-NOV-2012 filed on 02-NOV-2012
Memorandum of argument of Novartis AG filed on 02-NOV-2012
Court Reporter Invoice No. 18416 (sitting fee/transcript), 15,16,17-Oct-12 from ASAP received on 26-OCT-2012
Oral directions received from the Court: The Honourable Madam Justice Snider dated 17-OCT-2012 directing that Court room 5D and the break out rooms assigned to the parties for this trial shall remain sealed during the break until 6-NOV-2012. Only designated members from the parties and registry staff shall have access during this period. placed on file on 18-OCT-2012
Writ of Subpoena Ad Testificandum issued on 17-OCT-2012 cc filed
Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 17-OCT-2012 Tariff any other proceeding - $30.00
Invoice No. 18188 (sitting fee/transcript 1,2,3-Oct-2012_) from ASAP received on 11-OCT-2012
Invoice No. 18081 (sitting fee/transcript for 24,25,27-Sep-2012) from ASAP received on 10-OCT-2012
Supplementary Trial Record on behalf of Plaintiff filed at hearing on 03-OCT-2012
Book of authorities (re: motion doc. 250) consisting of 1 volume(s) on behalf of Plaintiff received on 24-SEP-2012
Motion Record in response to Motion Doc. No. 250 containing the following original document(s): 261 Number of copies received: 3 on behalf of Plaintiff filed at hearing on 24-SEP-2012
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 250 filed on 24-SEP-2012
Motion Record in response to Motion Doc. No. 243 containing the following original document(s): 259 Number of copies received: 3 on behalf of Plaintiff filed at hearing on 24-SEP-2012
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 243 filed on 24-SEP-2012
Loose case law (re: opening statement of the plaintiffs) received at hearing on 24-SEP-2012
Joint Book of Authorities (re: opening statement of the Plaintiff's) consisting of 2 volume(s) on behalf of Plaintiff received on 24-SEP-2012
Agreement (re: documentary evidence) on behalf of the parties received at hearing on 24-SEP-2012
Oral directions received from the Court: The Honourable Madam Justice Snider dated 18-SEP-2012 directing that the motion to appeal the order of Madame Tabib dated 6-SEP-2012 will be heard at 1pm on September 25th, 2012. Respondent motion records to be filed no later than beginning of trial 24-SEPT-2012. placed on file on 18-SEP-2012
Oral directions received from the Court: The Honourable Madam Justice Snider dated 18-SEP-2012 directing that the motions to strike portions of the latest amendments to pleadings by Novartis will be heard by the trial judge. Submissions will be made on when the motion is to be heard and procedure. placed on file on 18-SEP-2012
Solicitor's certificate of service on behalf of MARC RICHARD confirming service of ID: 490 upon Plaintiff by courrier on 18-SEP-2012 filed on 19-SEP-2012
Joint Book of Authorities (re: Motion doc. 250) consisting of 1 volume(s) on behalf of Defendant received on 19-SEP-2012 Sent directly to Presiding Judge
Writ of Subpoena Ad Testificandum issued on 19-SEP-2012 cc filed
Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 19-SEP-2012 Tariff any other proceeding - $30.00
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Book of Authorities upon Plaintiff by process server on 17-SEP-2012 filed on 18-SEP-2012
Book of Authorities (RE:Novartis motion to strike Reply-Doc.243) consisting of 1 volume(s) on behalf of Defendant received on 18-SEP-2012 Sent directly to Presiding Judge
Solicitor's certificate of service on behalf of Marc Richard confirming service of Doc.253 upon Plaintiff by personal service on 17-SEP-2012 filed on 17-SEP-2012
Motion Record containing the following original document(s): 250 251 252 Number of copies received: 3 on behalf of Defendant(3 VOL)**Note: Vol. 3 is SEALED and requires directions filed on 17-SEP-2012
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 250 filed on 17-SEP-2012
Affidavit of Erin McIntomny sworn on 17-SEP-2012 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 250 with Exhibits A-B(Confidential...in Vol.3; Affidavit in Vol.2) filed on 17-SEP-2012
Notice of Motion contained within a Motion Record on behalf of Defendant returnable before the presiding Trial Judge for an Order setting aside par. 1 of the September 6, 2012 Orde of Prothonotary Tabib and permitting Novartis to make the amendments struck by Prothonotary Tabib in relation to pargraphs 46A and 66 of Novartis' Third Amended Statement of defence and Counterclaim; In the alternative and if necessary, an Order granting leave to Novartis to make amendments struck by Prothonotary Tabib in relation to par. 46A and 66... filed on 17-SEP-2012
Letter from Plaintiff dated 14-SEP-2012 in reply to NOvartis letter dated 13-SEP-2012 (re: completion of discovery) received on 14-SEP-2012
Communication to the Court from the Registry dated 17-SEP-2012 re: Letters dated September 15 and 17th, and motion Doc. 243 sent to Court (Tabib, P.) for Directions re: when will motion be set down and who will preside?
Letter from Defendant dated 17-SEP-2012 writing further to the direction of Madam Justice Snider seeking "an explanation from Novartis on the purpose of the alleged "Trial Records" filed with the Court on September 12, 2012 and the authority for its filing" ...Novartis was surprised when it received trial records from Apotex and Teva which did not include the notices of allegation and notices of applications in T-599-11 and T-679-11. Novartis raised its concerns and requested that the trial records be corrected (see attached correspondence). However, Teva and Apotex refused to do so. Consequently, Novartis was forced to file separate records... received on 17-SEP-2012
Letter from Plaintiff dated 17-SEP-2012 "First, we echo the concerns rainsed in Mr. Cappe's letter on Saturday... Second...the motion was served out of time...and no request was made for short service or to validate service. Consequently, there is no motion properly to be heard on Wednesday. Third, our schedule for trial preparation involves me, personally, attending an out of office trial preparation...on September 19, 2012...Fourth, we expect the Court, once it is apprised of the nature of the complaints raised on these motions will recognize that they are simply an attempt to distract counsel, rather than motions seeking important or substantive relief....I reiterate Mr. Cappe's request that these motions be adjourned to be heard by Justice Snider, as she may direct. -scanned to the Court received on 17-SEP-2012
Letter from Defendant dated 17-SEP-2012 in response to Apotex's letter regarding Novartis' motions to strike in T-2021-10 and T-833-11. "...The timing of the motions was dictated by the timing of the receipt of Apotex's and Teva's amended pleadings...the issue should be resolved by Madam Prothonotary Tabib, who has dealt with all of the motions related to the pleadings in this case...we see no reasons why the motion cannot go forward with respect to, at the very least, Teva on September 19 as requested, assuming...that the Court is available at that time." In the alternative, if the Court wishes to grant additional time to Apotex, we are also available for a hearing on September 20th."-scanned to the Court received on 17-SEP-2012
Letter from counsel for Apotex in T-833-11 dated 15-SEP-2012 in response to Novartis' motions to strike in T-2021-10 and T-833-11, which were served upon Apotex and Teva on September 14th...Apotex submits that Novartis has not complied with the Rules of service and that such short notice is prejudicial to counsel to Apotex given that Mr. Brodkin and Mr. cappe will be observing Rosh Hashanah on both Monday and Tuesday. We request that these motions be adjourned to be heard by Justice Snider, as she may direct.-scanned to the Court received on 17-SEP-2012
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of doc.248 upon Plaintiff by personal service on 14-SEP-2012 filed on 14-SEP-2012
Motion Record containing the following original document(s): 243 244 245 246 247 Number of copies received: 3 on behalf of Defendant **NOTE: VOL. 2 is SEALED and is being sent for Direction filed on 14-SEP-2012
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 243 filed on 14-SEP-2012
Affidavit of Erin McIntomny (affidavit 3 of 3) sworn on 14-SEP-2012 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 243 with Exhibits I-J filed on 14-SEP-2012
Affidavit of Erin McIntomny (affidavit 2 of 3) sworn on 14-SEP-2012 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 243 with Exhibits G-H filed on 14-SEP-2012
Affidavit of Erin McIntomny (affidavit 1 of 3) sworn on 14-SEP-2012 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 243 with Exhibits A-F filed on 14-SEP-2012
Notice of Motion contained within a Motion Record on behalf of Defendant requesting a special sitting b/f Madam Prothonotary Tabib in OTT 19-SEP-12 for an Order pursuant to Rule 221 striking the parenthetical that states "(including a naturally-occurring tumor)" in paragraph 32A of Teva's Sept. 13, 2012 Second Amended Reply and Defence to Counterclaim.; an Order granting solicitor client costs...;In the alternative, if the Court denies this motion in whole or in part, Novartis requests further examinations for dicovery, leave to amend Novartis' expert reports in chief and/or leave to deliver reply reports. ***NOTE: Volume 2 is sealed and is being sent for Direction*** filed on 14-SEP-2012
Writ of Subpoena Duces Tecum issued on 17-SEP-2012 cc filed
Request for Writ(s) of Subpoena Duces Tecum on behalf of Defendant filed on 14-SEP-2012 Tariff any other proceeding - $30.00
Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of Doc. 239 upon Defendant by telecopier on 13-SEP-2012 filed on 13-SEP-2012
Amended (Second) Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 13-SEP-2012
Letter from Defendant dated 13-SEP-2012 our client has been unable to complete discovery of Apotex with respect to the recent regulatory use amendment and is concerned that the discovery will not be completed before trial. Without complete and immediate compliance with the representations made by APotex that resulted in their amendments, we will not be ready to proceed. received on 13-SEP-2012
Minutes of TMC prepared by Teva Canada Inc. Minutes approved by the court and parties as to content received on 21-AUG-2012
Covering letter from Defendant dated 12-SEP-2012 concerning Novartis' Trial Record and doc. 238 placed on file on 12-SEP-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Novartis' Trial Record upon Plaintiff by courier on 11-SEP-2012 filed on 12-SEP-2012
Solicitor's certificate of service on behalf of Jennifer confirming service of Doc#236 upon Plaintiff by e-mail (on consent) on 11-SEP-2012 filed on 11-SEP-2012
Fourth Amended Statement of Defence and Counterclaim filed on 11-SEP-2012
Acknowledgment of Receipt received from all parties by email with respect to Doc. 235 placed on file on 07-SEP-2012
Order dated 06-SEP-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 221 Result: granted in part 1. The following amendments made by Novartis in its Third Amended Statement of Defence and Counterclaim dated July 20, 2012 are hereby struck, without leave to amend, and Novartis is to serve and file a Fourth Amended Statement of Defence and Counterclaim in which those amendments are rmoved and, where appropriate, the paragraphs or portions thereof are returned to their previous version: (see Order for details) 2. Teva's amended reply and defence to counterclaim, if any, is to e served and filed within 5 days of this Order. 3. Costs of this motion, int he amount of $2500 plus disbursements, shall be in the cause. Filed on 06-SEP-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1167 page(s) 427 - 433 Interlocutory Decision
Ottawa 28-AUG-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 221 on behalf of Plaintiff to strike improper amendments of Novartis AG's Third Amended Statement of Defence and Counterclaim; and for an Order granting Teva leave to deliver a Second Amended Reply and Defence to Counterclaim Result of Hearing: Matter reserved held in Court Senior Usher: Gendron, P. Duration per day: 28-AUG-2012 from 09:30 to 02:05 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 4h35min Appearances: Jonathan Stainsby 416-360-3663 representing Teva Canada Ltd. Arthur Renaud/Isabel Jaen Raasch 613-786-0156 representing Defendant In T-833-11:Andrew Brodkin/Daniel Cappe 416-979-2211 representing Apotex Inc Comments: Heard together with Apotex's motion in T-833-11 (Motion Doc.131) Minutes of Hearing entered in Vol. 866 page(s) 469 - 483 Abstract of Hearing placed on file
Affidavit of service of Erin McIntomny sworn on 24-AUG-2012 on behalf of Defendant confirming service of Joint Book of Authorities upon Plaintiff by courier on 23-AUG-2012 filed on 24-AUG-2012
Joint Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 24-AUG-2012 Sent directly to Presiding Judge
Solicitor's certificate of service on behalf of Adrian Howard confirming service of responding motion record (doc.231 and 232) upon Plaintiff by by hand on 22-AUG-2012 filed on 22-AUG-2012
Sealed envelope pursuant to Confidentiality Order dated December 13, 2011 on behalf of NOVARTIS AG purporting to contain Volume 2 of 2 of the responding motion record filed on August 22, 2012 in opposition to Teva's August 16, 2012 motion to Strike portions of Novartis's Third Amended Statement of Defence and Counterclaim dated July 27, 2012 Filed on 22-AUG-2012
Motion Record in response to Motion Doc. No. 221 containing the following original document(s): 228 229 230 Number of copies received: 3 on behalf of Her Majesty The Queen NOVARTIS AG (2 volumes ; Volume 2 of 2 is confidential) filed on 22-AUG-2012
Written Representations on behalf of Novartis AG concerning Motion Doc. No. 221 filed on 22-AUG-2012
Affidavit of Erin McINTOMNY sworn on 22-AUG-2012 on behalf of NOVARTIS AG in opposition to Motion Doc. No. 221 with Exhibits G-H-I filed on 22-AUG-2012
Affidavit of Erin McINTOMNY sworn on 22-AUG-2012 on behalf of NOVARTIS AG in opposition to Motion Doc. No. 221 with Exhibits A-F filed on 22-AUG-2012
Writ of Subpoena Ad Testificandum issued on 21-AUG-2012 cc filed
Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 21-AUG-2012 Tariff any other proceeding - $30.00
Letter from Plaintiff dated 21-AUG-2012 outlining physical resource requests for trial to begin in Toronto on 24-SEP-2012 received on 21-AUG-2012
Solicitor's certificate of service on behalf of Lesley Caswell confirming service of Doc 224 and a Joint Book of Authorities upon Defendant by personal service on 16-AUG-2012 filed on 16-AUG-2012
Joint Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 16-AUG-2012
Motion Record containing the following original document(s): 221 222 223 Number of copies received: 3 on behalf of Plaintiff filed on 16-AUG-2012
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 221 filed on 16-AUG-2012
Affidavit of Anna Hucman sworn on 16-AUG-2012 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 221 with Exhibits A-J filed on 16-AUG-2012
Notice of Motion contained within a Motion Record on behalf of Plaintiff Tuesday August 28, 2012 @ 9:30 to Prothonotary Tabib for an Order to strike improper amendments to the statement of defence filed on 16-AUG-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-AUG-2012 directing that the plaintiff's motions to amend pleadings is set down for 9:30 am on August 28, 2012 not to exceed one-half day in Ottawa. Plaintiff's motion records are due 16-AUG-2012 and responding motion records are due 22-AUG-2012 placed on file on 15-AUG-2012
Solicitor's certificate of service on behalf of ANDREW MCINTYRE confirming service of TRIAL RECORD (DOC. 219) upon Defendant by personal service on 15-AUG-2012 filed on 15-AUG-2012
Trial Record on behalf of Plaintiff filed on 15-AUG-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 10-AUG-2012 directing that given Mr. Creber's unavailability to argue a motion on August 28 or 29, the court requests that alternate counsel be assigned to argue or if this is not possible submissions on why the motion should be set to an alternate date. placed on file on 10-AUG-2012
Letter from Defendant Novartis AG dated 13-AUG-2012 "This is further to my email exchange with Mr. Schutz of the Toronto Registry on Friday, August 10, 2012. Given that Teva prefers to have the Motion argued on the morning of August 28, and Apotex has not stated a preference, we propose that the Motion be heard during the morning of August 28 to accommodate Teva's request. However, if the Court prefers August 29, 2012, we are also available on that date." received on 13-AUG-2012
Letter from Apotex Inc. on their own behalf and on behalf of Teva Canada Ltd. dated 09-AUG-2012 re: Further to the TMC held with Snider, J. earlier today, requesting Prothonotary Tabib's availability to adjudicate Motions to strike portions of Novartis AG's amended pleadings... Counsel for Apotex and Teva are generally available for a hearing of the Motions during the remainder of the month of August or the first week of September, in Toronto or Ottawa... received on 09-AUG-2012
Toronto 09-AUG-2012 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: for primary minutes please refer to T-833-11 vol. 866 pp. 241-247 held by way of Conference Call Duration per day: 09-AUG-2012 from 09:04 to 09:54 Courtroom : Judge's Chambers - Toronto Court Registrar: Jake Schutz Total Duration: 50min Appearances: Andrew Brodkin 416-597-4278 representing plaintiff (Apotex) Dino Clarizio 416-597-4278 representing plaintiff (APotex) Daniel Cappe 416-597-4278 representing plaintiff (Apotex) Nando De Luca 416-597-4278 representing plaintiff (Apotex) Jonathan Stainsby 416-360-3568 representing plaintiff (Teva) Andrew Skodyn 416-360-3568 representing plaintiff (Teva) Andrew McIntyre 416-360-3568 representing plaintiff (Teva) Anthony Creber 613-786-0140 representing Defendant Isabel Raasch 613-786-0140 representing Defendant Minutes of Hearing entered in Vol. 866 page(s) 248 - 249 Abstract of Hearing placed on file
Letter from APotex Inc. dated 07-AUG-2012 replying to Novartis AG response letter of 7-AUG-2012 received on 08-AUG-2012
Letter from Novartis AG dated 07-AUG-2012 indicating the items it would like to address at the TMC on 9-AUG-2012 received on 07-AUG-2012
Letter from Apotex Inc., and on behalf of Teva Canada Limited dated 07-AUG-2012 in response to Novartis AG's letter requesting a case management meeting. Counsel would like to add items to the agenda for the CMC on August 9, 2012. Scanned to Justice Snider received on 07-AUG-2012
Counsel minutes of hearing for trial management conference that took place on 18-JUL-2012. Form and content approved by Madame Justice Snider and all parties to the litigation. placed on file on 01-AUG-2012
Toronto 18-JUL-2012 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: for main minutes see T-833-11 vol. 865 p. 423 held in chambers Duration per day: 18-JUL-2012 from 01:03 to 01:52 Courtroom : Judge's Chambers - Toronto Court Registrar: Jake Schutz Total Duration: 49min Appearances: Andrew Brodkin 416-979-2211 representing plaintiff (Apotex) Dino Clarizio 416-979-2211 representing plaintiff (Apotex) Michel Anderson 416-979-2211 representing plaintiff (Apotex Jon Stainsby 416-360-6336 representing plaintiff (Teva) Andrew Mcintyre 416-360-6336 representing plaintiff (Teva) Anthony Creber 613-233-1781 representing Defendant Isabel Raasch 613-233-1781 representing Defendant Arthur Renaud 613-233-1781 representing Defendant John Norman 613-233-1781 representing Defendant Jennifer Wilkie 613-233-1781 representing Defendant Minutes of Hearing entered in Vol. 866 page(s) 69 - 70 Abstract of Hearing placed on file
Oral directions received from the Court: The Honourable Madam Justice Snider dated 27-JUL-2012 directing that "The Court will schedule a trial management conference (TMC) for 9am on Thursday August 9, 2012 by teleconference. However the Court expects that the parties will make best efforts to resolve some or all of the matters raised in the letter prior to the TMC." placed on file on 27-JUL-2012 Confirmed in writing to the party(ies)
Letter from Defendant-Apotex(T-599-11) dated 27-JUL-2012 with regard to the letter from Counsel(Novartis AG, dated 26-jul-2012 , agreeing to a further TMC on 9-aug-2012. received on 27-JUL-2012
Letter from counsel for Novartis dated 26-JUL-2012 requesting a short case/trial management conference. received on 26-JUL-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc#217 upon Defendant by having a copy of the document delivered electronically on consent on 20-JUL-2012 filed on 20-JUL-2012
Amended (Third) Statement of Defence abd Counterclaim filed on 20-JUL-2012
Copy of Oral Direction dated 11-JUL-2012 rendered by The Honourable Madam Justice Snider concerning motion on appeal "The motion on appeal will be heard in person in Toronto after the trial management teleconference meeting." placed on file. Original filed on Court File No. T-833-11
Letter from counsel representing Novartis dated 10-JUL-2012 "...We also acknowlege receipt of the instruction that the Appeal of the decision of Prothonotary Tabib relating to Apotex's amendment will be heard right after the Trial Management conference. We are open to having this heard by telephone conference or in person; however Mr. Creber will not be arguing this Appeal due to his unavailability." received on 10-JUL-2012
Copy of correspondence (by email) from solicitors for Apotex Inc. in T-833-11. dated 09-JUL-2012 placed on file on 10-JUL-2012 Original placed on Court File No. T-833-11
Copy of Oral Direction dated 09-JUL-2012 rendered by The Honourable Madam Justice Snider concerning the Notice of Motion on behalf of Apotex (T-833-11/Doc. No.111) "Motion to be heard July 18, 2012 immediately following the trial management conference scheduled for 1 p.m." placed on file. Original filed on Court File No. T-833-11
Written directions received from the Court: The Honourable Madam Justice Snider dated 09-JUL-2012 directing that A trial management conference, as provided for in Rule 270 of the Federal Courts Rules, will be held in respect of Court File Nos. T-2021-10 and T-833-11, on Wednesday, July 18, 2012, by teleconference, commencing at 1:00 p.m. -Please see attached Direction for more information- placed on file on 09-JUL-2012 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from all parties, by email, confirming receipt June 29, 2012 with respect to doc. 216 placed on file on 29-JUN-2012
Order dated 29-JUN-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Pre-Trial Conference Result: (PTC continued from June 20, 2012 to June 29, 2012) 1. The Trial of this matter will take place in Toronto. 2. A trial management teleconference will be held at 1:00p.m. Eastern Time, on July 18, 2012. 3. Apotex will serve and file a full motion record on its motion to appeal no later than July 4, 2012. 4. Novartis shall serve and file its responding record no later than July 11, 2012. 5. The parties shall provide to the trial Judge their dates of non-availability for a hearing of the motion to appeal by no later than July 4, 2012. 6. The translations and affidavits required by Rule 68(1) shall be served no later than August 15, 2012. (Order entered in Ottawa) Filed on 29-JUN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1162 page(s) 111 - 113 Interlocutory Decision
****** CANCELLED ****** Letter from Apotex Inc. dated 29-JUN-2012 We write further to our attempt to e-file, yesterday, an electronic copy of our Notice of Motion regarding an appeal from the order of Tabib, P. dated June 19, 2012. We received a notice that there was a problem and that it should be transmitted by fax. A copy of this document is attached and Apotex requests that it be accepted for filing....Apotex hereby requests that its motion be made returnable before the Trial Judge, Snider, J. on either July 18 or 19, 2012..." received on 29-JUN-2012
Ottawa 29-JUN-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Pre-Trial Conference Result of Hearing: An Order will issue. Parties are to remain available for a Trial Management Conference with the Trial Judge on July 18, 2012 at 1:00p.m.EST. The scheduling of the TMC will be confirmed to parties next week. Heard together with T-833-11. held in chambers by way of Conference Call Duration per day: 29-JUN-2012 from 09:30 to 11:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1h30min Appearances: Andrew Skodyn/Andrew McIntyre 416-360-3498 representing Teva Andrew Brodkin/Dino Clarizio/Daniel Cappe/Nando De Luca 416-597-4278 representing Apotex Anthony Creber/Isabel Raasch 613-786-0140 representing Novartis Comments: Note: Mr. Creber will be participating at the trial management conference from overseas. A contact number will be provided prior to the hearing. Minutes of Hearing entered in Vol. 865 page(s) 129 - 141 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 28-JUN-2012 directing that "The Court acknowledges Counsel for Novartis' letter of June 25, 2012. All parties are now aware of the identity of the trial judge. As mentioned at the hearing of June 14, 2012 in the presence of all parties, the early disclosure was made in the context of a social conversation. The litigation was otherwise not discussed." placed on file on 28-JUN-2012 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from all parties by FAX and by email with respect to Doc.201 placed on file on 19-JUN-2012
Acknowledgment of Receipt received from all parties by email June 22 with respect to doc.214 placed on file on 22-JUN-2012
Witness Chart detailing the statement of the witnesses' position and the subject matter, submitted on behalf of Novartis in compliance with the Order of the Court dated June 22, 2012 with indication of service upon all parties on 26-JUN-2012 filed on 26-JUN-2012
Letter from Novartis dated 25-JUN-2012 Re: Disclosure of Trial Judge received on 25-JUN-2012
Order dated 22-JUN-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Pre-Trial Conference Result: 1. The pre-trial conference herein will resume by teleconference on June 29, 2012 at 9:30a.m. 2. As the trial Judge will not be participating in the PTC, the parties are to provide to the Trial Judge, no later than June 22, 2012, their dates of non-availability to participate in a trial management conference in the next 5 weeks, indicating whether thay are available in person or by telephone conference and if in person, their preferred venue. 3. Novartis will, no later than the end of the day on June 26, 2012, serve and file a chart indicating, for each potential witness on the list found in its PTC memorandum, a short statement of the witness' position, the subject matter to which they might testify, and where witnesses might be called as alternate for others. 4. The parties shall serve on each other, no later than July 31, 2012, any notice to admit facts or documents. 5. The parties shall notify each other of the excerpts of the discovery transcripts and ansers to undertakings which they intend to read in at trial no later than August 30, 2012. 6. Requests for additional read-ins shall be communicated no later than September 17, 2012. 7. The parties shall provide to each other will-say statements 10 days prior to the date on which the witness is expected to testify. Filed on 22-JUN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1161 page(s) 309 - 312 Interlocutory Decision
Letter from Apotex Inc. dated 22-JUN-2012 advising the Court of their dates of non-availability for a Trial Management Conference in July. received on 22-JUN-2012
Covering letter from Plaintiff dated 22-JUN-2012 concerning Doc. No. 213 placed on file on 22-JUN-2012
AMENDED Public Version of Volume 1 (Doc 181) pursuant to direction of Tabib, P during PTC held on June 20, 2012. filed on 22-JUN-2012
Brief of references cited in teh statement of Dr. Richard Van Etten dated June 22, 2012 received on 22-JUN-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc.211 upon all parties by electronic mail on consent on 22-JUN-2012 filed on 22-JUN-2012
SEALED Expert Report of Dr. Richard Van Etten dated June 22, 2012 filed on 22-JUN-2012
Brief of references cited in the statement of Dr. Stephen P. Goff dated June 22, 2012 received on 22-JUN-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc.209 upon all parties by electronic mail on consent on 22-JUN-2012 filed on 22-JUN-2012
SEALED Expert Report of Stephen P. Goff dated June 22, 2012 filed on 22-JUN-2012
Letter from Teva Cda. dated 22-JUN-2012 Re: dates of non-availability for a trial managment conference "Counsel for Teva Canada are not available July 2 to 6,9,10 and 16." received on 22-JUN-2012
Letter from Novartis AG dated 22-JUN-2012 ...We are not available for a Trial Management Conference on or between July 12 and 25 and our desired method for conducting the same is via teleconference or in Ottawa, if live. received on 22-JUN-2012
Covering letter from Defendant dated 20-JUN-2012 concerning Doc. Nos. 206 207 placed on file on 20-JUN-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of docs.206 & 207 upon all parties by email on consent on 20-JUN-2012 filed on 20-JUN-2012
Sealed EXPERT REPORT of Dr. James Wuest, dated June 19, 2012, on behalf of Novartis AG filed on 20-JUN-2012
Brief of References Cited in Expert Report of Dr. Carl-Henrik Heldin received on 20-JUN-2012
Sealed EXPERT REPORT of Dr. Carl-Henrik Heldin dated 19-JUN-2012, on behalf of Novartis AG (1 original; 1 judge's copy) filed on 20-JUN-2012
Solicitor's certificate of service on behalf of Andrew Skodyn confirming service of Doc 204 upon Defendant by email and overnight courier on 21-JUN-2012 filed on 21-JUN-2012
Amended (Second) Statement of Claim filed on 21-JUN-2012
Covering letter from Novartis AG and Novartis Pharmaceuticals Canada Inc. dated 20-JUN-2012 concerning Doc. No. 202 placed on file on 20-JUN-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Expert Report of Dr. Ronald Sawchuk dated June 20, 2012 (Doc.202) upon all parties by electronic mail on consent on 20-JUN-2012 filed on 20-JUN-2012
SEALED Expert Report of Dr. Ronald Sawchuk dated June 20, 2012 Report re: further to Pre Trial Conference of June 20, 2012 filed on 20-JUN-2012
Ottawa 20-JUN-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Pre-Trial Conference Result of Hearing: To be continued on July 29, 2012 (Time to be determined) Novartis will be serving and filing 3 of their Expert Reports today, and the remaining 2 will be submitted on Friday, June 22nd. Mr. Creber is to provide to the Court and all counsel, a short statement of each witness' position and subject matter by June 26, 2012. Venue of the trial is to be determined by the Court. Any appeals of the Court's decisions rendered on June 19, 2012 will be dealt with by the Trial Judge. Parties are to provide their dates of non-availability for a trial management conference by June 22, 2012, and are to distinguish if they want it to be heard by teleconference or in person (desired venue to be included). Heard together with T-833-11. held in chambers by way of Conference Call Duration per day: 20-JUN-2012 from 10:00 to 12:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 2h Appearances: A. Skodyn/A. McIntyre 416-849-6944 representing Plaintiff A. Creber/J. Wilkie/I. Raasch 613-786-0140 representing Defendant Minutes of Hearing entered in Vol. 864 page(s) 274 - 288 Abstract of Hearing placed on file
Reasons for Order and Order dated 19-JUN-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 179 Result: granted in part 1. Teva has leave to serve and file an amended Statement of Claim in the form set out in Schedule "A" of its Notice of Motion, with the following exceptions: a) Proposed par. 20(b)i is to be modified so as to replace "hyperproliferative disorders" with the words "tumors and atherosclerosis ("hyperproliferative disorders")". b) Proposed paragraph 21A; the sentence in proposed par.25 beginning with "Rather" and ending with "utility"; the words "types of" in par. 31 and 33; and proposed par.34 may not be included. 2.Teva's undertaking, as set out in paragraph 36 of the Reasons for Order in Apotex v Novartis, 2012 FC 786 is noted and is to be given effect to. 3.With costs in favour of Novartis at the high end of Column V of the Tariff Filed on 19-JUN-2012 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1161 page(s) 76 - 77
Ottawa 14-JUN-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 179 on behalf of the Plaintiff (Teva) Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 194 on behalf of the Defendant/Plaintiff by Counterclaim (Novartis AG) Motion for Extension of Time to File two Expert Reports Result of Hearing: Granted (Parties agreed verbally and orally during the hearing) held in Court Duration per day: 14-JUN-2012 from 01:35 to 05:35 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Catherine Doré 15-JUN-2012 from 11:00 to 01:40 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Catherine Doré Total Duration: 6h40min Appearances: Mr. Andrew Brodkin & Ms. Michel Anderson (416) 979-2211 representing Apotex (T-833-11) Mr. Anthony Creber & Ms. Isabel Jaen Raasch (613) 786-0140 representing Defendant (Novartis AG) Mr. Andrew McIntyre (416)643-6930 representing Teva Canada Limited Comments: Oral Direction was issued. Minutes of Hearing entered in Vol. 864 page(s) 159 - 180 Abstract of Hearing placed on file
Letter from Teva dated 18-JUN-2012 Further to the motion held last Thursday and Friday, and Prothonotary Tabib's request that the parties provide dates of availability for a second PTC to be held during the last week of June, please be advised that Teva is generally available June 28 and 29... received on 18-JUN-2012
PLEADINGS BRIEF received on 15-JUN-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Pre-trial Conference Brief (Doc.199) upon all parties by electronic mail on consent on 15-JUN-2012 filed on 15-JUN-2012
Pre-trial Conference Brief on behalf of Novartis AG, and Novartis Phramaceuticals Canada Inc. filed on 15-JUN-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-JUN-2012 directing that "Teva and Apotex are to submit a copy of their proposed Amended pleading to be inserted at the appropriate place in the Public Versions of their Motion Record." placed on file on 15-JUN-2012
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc.197 upon Teva and Apotex by personal service on 13-JUN-2012 filed on 13-JUN-2012
Motion Record containing the following original document(s): 194 195 196 Number of copies received: 2 on behalf of Novartis AG filed on 13-JUN-2012
Written Representations contained within a Motion Record on behalf of Novartis AG concerning Motion Doc. No. 194 filed on 13-JUN-2012
Affidavit of John Norman sworn on 13-JUN-2012 contained within a Motion Record on behalf of Novartis AG in support of Motion Doc. No. 194 with Exhibits A-B filed on 13-JUN-2012
Draft Order concerning Motion Doc. No. 194 received on 13-JUN-2012
Notice of Motion contained within a Motion Record on behalf of Novartis AG in writing to be placed before the Court in Ottawa for an extension of time to file two reports from Novartis' experts by June 22, 2012 (instead of 15-JUN-12) and for an Order abridging the time for bringing this motion pursuant to Rule 362(2)(b)**NOTE: This motion may be heard at the general sittings in Ottawa on June 14, 2012. To be determined at hearing. filed on 13-JUN-2012
Letter from Novartis AG dated 12-JUN-2012 Further to the Scheduling order dated January 18, 2012 stating that responding expert reports are due June 15, 2012, we are seeking a short extension of time for two of our five responding expert reports...Teva and Apotex are seeking instructions regarding consent...we can provide evidence supporting our request at the hearing on June 14, 2012 in Ottawa. We request the Court's guidance if a full motion record is necessary. (scanned) received on 12-JUN-2012
On June 12/12 the Defendant submitted for the Court's convenience, 3 coipes of Canadian Patent No. 2,093,203 already before Court in T-833-11 ... scheduled June 14/12, but was not included in the Teva or Novartis Records in the witin proceeding. The Solicitor's Cert. of Service Doc 193 and cover letter dated June 12/12 (ID 368) support this submission. with indication of service upon Plaintiff on 11-JUN-2012 received on 12-JUN-2012
Covering letter from Defendant dated 12-JUN-2012 concerning Doc. No. 192 placed on file on 12-JUN-2012
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Doc 192 upon Plaintiff by courier on 11-JUN-2012 filed on 12-JUN-2012
Transcript of cross-examination held on 30-MAY-2012 RE: Affidavit of Anna Hucman filed on 12-JUN-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 11-JUN-2012 directing that "Further to the correspondence on behalf of Novartis AG dated June 4, 2012, the Court confirms that the discussion during the May 25th CMC surrounded Novartis AG's concerns with respect to the expert reports prepared by Apotex and Teva. It is clarified that the statement attributed to Mr. Norman in the May 25th Minutes of Hearing is in reference to the Plaintiffs' expert reports, such that: "Mr. Norman submits that the Plaintiffs' reports are based on the amended pleadings." A copy of this Direction is to be appended to the May 25th Minutes of Hearing." placed on file on 12-JUN-2012 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Book of Authorities upon Plaintiff by courier on 08-JUN-2012 filed on 11-JUN-2012
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 11-JUN-2012 Sent directly to Presiding Judge
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of the Defendant's Responding Motion Record upon Plaintiff by personal service on 06-JUN-2012 filed on 06-JUN-2012
Motion Record in response to Motion Doc. No. 179 containing the following original document(s): 185 186 187 Number of copies received: 3 on behalf of Defendant filed on 06-JUN-2012
Sealed envelope pursuant to the Order of the Court dated 13-DEC-2011 on behalf of Defendant purporting to contain Exhibit C to the Affidavit of Erin McIntomny sworn 6-JUN-2012 Filed on 06-JUN-2012
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 179 filed on 06-JUN-2012
Affidavit of Peter Waibel sworn on 06-JUN-2012 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 179 filed on 06-JUN-2012
Affidavit of Erin McIntomny sworn on 06-JUN-2012 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 179 with Exhibits A, B, C (confidential - Vol. 2) filed on 06-JUN-2012
Memorandum to file from Case Management Team, Ottawa dated 05-JUN-2012 Upon speaking to Mr. John Norman, counsel for Novartis AG, in reference to his letter dated June 4, 2012, he has clarified that he would like the record to reflect that it is the "plaintiffs" expert reports that are based on the amended pleadings rather than the "applicants". (June 4, 2012 letter and memo to file were communicated to the Court by email) placed on file.
Letter from Novartis AG dated 04-JUN-2012 We have just reviewed the Minutes of Hearing dated May 25, 2012...Upon reviewing the notes we have discovered an incorrect entry on page 4 of 4... We would like to inform the Court and have the record corrected to show that the Applicant's expert reports are not based on the amended pleadings. (scanned) received on 04-JUN-2012
Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of DOC 183 upon Defendant by e-mail on 01-JUN-2012 filed on 01-JUN-2012
Sealed envelope pursuant to Protective Order on behalf of Plaintiff purporting to contain Pre-Trial Conference Memorandum of the Plaintiff, Teva Canada Limited Filed on 01-JUN-2012
Solicitor's certificate of service on behalf of ANDREW MCINTYRE confirming service of MOTION RECORD (DOC. 181) upon Defendant by COURIER on 30-MAY-2012 filed on 30-MAY-2012
PLEADINGS BRIEF (MOTIONS TO AMEND PLEADINGS)(RE: NOTICE OF MOTION DOC. 179) received on 30-MAY-2012
BOOK OF AUTHORITIES (RE: NOTICE OF MOTION DOC. 179) consisting of 1 volume(s) on behalf of Plaintiff received on 30-MAY-2012
Motion Record containing the following original document(s): 179 180 Number of copies received: 3 on behalf of Plaintiff (3 VOLS. - V. 2 AND V. 3 ARE SEALED) filed on 30-MAY-2012
Affidavit of ANNA HUCMAN sworn on 30-MAY-2012 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 179 with Exhibits A-M filed on 30-MAY-2012
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at General Sitting in Ottawa on 14-JUN-2012 to begin at 13:30 duration: 2h language: E for an Order GRANTING TEVA CANADA LEAVE TO FILE ITS SECOND AMENDED STATEMENT OF CLAIM AND OTHER RELIEF. filed on 30-MAY-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 25-MAY-2012 directing that RE: Apotex and Teva's motions to amend "The Plaintiffs' moving motion records shall be served and filed by May 30, 2012. The responding motion records shall be served and filed by June 6, 2012. The Plaintiffs motions shall be heard at the general sittings in Ottawa, beginning at 1:30p.m. on June 14, 2012." placed on file on 25-MAY-2012 Confirmed in writing to the party(ies)
Ottawa 25-MAY-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss Teva and Apotex's intended motions to amend their claims Result of Hearing: A Direction will issue//Clients are not required to attend the PTC on June 20, 2012; Parties are to provide a list of witnesses in their PTC memoranda. held in chambers by way of Conference Call Duration per day: 25-MAY-2012 from 02:30 to 03:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 30min Appearances: A. Skodyn/J. Stainsby 416-360-3568 representing Teva Cda. Ltd. J. Norman/J. Wilkie 613-783-8848 representing Novartis D. Clarizio(T-833-11) 416-597-4140 representing Apotex Inc. Minutes of Hearing entered in Vol. 862 page(s) 468 - 471 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 24-MAY-2012 directing that "A case management telephone conference will be held at 2:30P.M. on May 25, 2012." placed on file on 24-MAY-2012 Confirmed in writing to the party(ies)
Letter from Novartis AG dated 22-MAY-2012 in response to Apotex and Teva's correspondence of today's date. Although they disagree with the proposed amendments being minor in nature, they are available for a case conference this week. received on 22-MAY-2012
Letter from Teva dated 22-MAY-2012 agreeing with the contents of Apotex's letter and also request a case management conference. received on 22-MAY-2012
Letter from Apotex Inc. dated 22-MAY-2012 indicating that they sought consent from Novartis to make minor amendments to Apotex's Amended Stetment of Claim and Reply and Defence to Counterclaim. Teva also sought Novartis' consent to make similar amendments to Teva's Amended Statement of Claim....Novartis advised that their client will not consent to the amendments. Accordingly, both Apotex and Teva intend to bring motions to amend...and request a case management teleconference... received on 22-MAY-2012
Order dated 24-APR-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 155 Result: granted in part 1. Novartis will provide an answer to Item 7, Q.2354. 2. Novartis does not need to provide further answers for Items 2,4,5 and 6. Filed on 24-APR-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1155 page(s) 176 - 178 Interlocutory Decision
Order dated 24-APR-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 144 Result: granted in part 1. With respect to the questions that Teva is ordered to answer (as set out above), answers in writing shall be provided by a date to be agreed upon by the parties. Filed on 24-APR-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1155 page(s) 171 - 175 Interlocutory Decision
Letter from Novartis dated 12-APR-2012 on consent of Apotex and Teva, attaching two draft orders for the motions to compel Dr. Mathivanan (T-2021-10 heard Feb. 29, 2012) and Mr. Waible (T-2021-10 & T-833-11 heard March 9, 2012)-scanned received on 12-APR-2012
Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of Docs.: 172 to 175 and ID: 331,333 and 335 upon NOVARTIS by overnight courier on 30-MAR-2012 filed on 30-MAR-2012
Sealed envelope pursuant to direction of April 4, 2012 and Order of January 18, 2012 on behalf of TEVA purporting to contain the EXPERT REPORT of Dr. James Brophy dated March 30, 2012 (2 copies filed in T-2021-10; 1 copy filed in T-833-11) Filed on 30-MAR-2012
Brief of References cited in the EXPERT REPORT of Dr. Ronnstrand dated March 29, 2012 received on 30-MAR-2012
Sealed envelope pursuant to direction of April 4, 2012 and Order of January 18, 2012 on behalf of TEVA purporting to contain the EXPERT REPORT of Dr. Lars Ronnstrand dated March 29, 2012 (2 copies in T-2021-10; 1 copy in T-833-11) Filed on 30-MAR-2012
Brief of References cited in the EXPERT REPORT of Dr. Heathcock dated March 30, 2012 received on 30-MAR-2012
Sealed envelope pursuant to direction of April 4, 2012 and Order of January 18, 2012 on behalf of TEVA purporting to contain the EXPERT REPORT of Dr. Clayton Heathcock dated March 30, 2012. (2 copies in T-2021-10 and 1 copy in T-833-11) Filed on 30-MAR-2012
Brief of References cited in the EXPERT REPORT of Dr. Zilberstein, dated March 30, 2012 received on 30-MAR-2012
Sealed envelope pursuant to direction dated April 4, 2012 and Order dated January 18, 2012 on behalf of TEVA purporting to contain the EXPERT REPORT of Dr. Asher Zilberstein (1 copy filed in T-833-11) Filed on 30-MAR-2012
Letter from Plaintiff(TEVA) dated 30-MAR-2012 Further to the letter submitted by Novartis yesterday please find enclosed the following expert reports in chief on behalf of the Plaintiffs:... Please note the expert reports are being filed as part of the pre-trial conference materials pursuant to the Order dated January 18, 2012...the reports contain confidential information and are being filed in sealed envelopes. We respectfully request that the Court keep this material confidential until the issues with repect to the Confidentiality Order raised in Mr. Howard's letter are resolved. received on 30-MAR-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 04-APR-2012 directing that Because expert reports are typically filed with the Court as pre-trial conference materials, and because such materials are held in seperate files not accessible to the public, the Court will allow the reports as filed on March 30, 2012, to remain sealed pending the filing of a motion for a confidentiality Order. The parties should note that this direction only avails for the filing of the reports pursuant to the Order of January 18, and does not constitute a standing direction to file such reports again under seal, whether it be in support of any future interlocutory motion or in evidence at the trial. placed on file on 05-APR-2012 Confirmed in writing to the party(ies)
Memorandum to file from Christen Clement dated 29-MAR-2012 Re: Novartis' letter dated March 29, 2012. I have advised all counsel by email today that given the case management Judge's absence until April 2, 2012, parties may submit their expert reports confidentially on March 30th pending a direction of the Court regarding a confidentiality order. All reports are to be "received" and sent to the Case Management Team in Ottawa. placed on file.
Letter from Novartis dated 29-MAR-2012 seeking leave to submit their expert reports confidentially on March 30th pending a confidentiality order. (Letter written on consent of Teva and Apotex) received on 29-MAR-2012
Ottawa 09-MAR-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 155 on behalf of Teva and Apotex Result of Hearing: Matter partially granted held in chambers by way of Conference Call Duration per day: 09-MAR-2012 from 01:00 to 01:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 35min Appearances: Andrew Skodyn/Andrew McIntyre 416-360-6336 representing Teva Daniel Cappe (sat with counsel for Teva) representing Apotex Inc. John Norman/Adrian Howard 613-783-8848 representing Novartis Comments: An Order will follow upon receipt of a draft order from parties. Minutes of Hearing entered in Vol. 858 page(s) 433 - 436 Abstract of Hearing placed on file
Covering letter from NOVARTIS dated 08-MAR-2012 concerning Doc. Nos. 170 171 placed on file on 08-MAR-2012
Affidavit of service of Erin McIntomny sworn on 08-MAR-2012 on behalf of Defendant confirming service of 170 upon Plaintiff by personal service on 08-MAR-2012 filed on 08-MAR-2012
Supplemental Documents (Responding Motion Record, Motion to Compel) filed on 08-MAR-2012
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAR-2012 directing that The Plaintiff's (Apotex and Teva) motion to compel filed February 21, 2012 will be heard by teleconference on March 9, 2012 at 1:00p.m. placed on file on 06-MAR-2012 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of Adrian Howard confirming service of the Book of Authorities upon Plaintiff (Defendant by Counterlcaim) by courier on 02-MAR-2012 filed on 05-MAR-2012
Book of Authorities consisting of 1 volume(s) on behalf of The Defendant (Plaintiff by Counterclaim) received on 05-MAR-2012
Sealed envelope pursuant to Amended Protective Order and Confidentiality Order issued December 13, 2011 on behalf of NOVARTIS purporting to contain the Confidential version of the responding motion record (Doc.166) Filed on 02-MAR-2012
Solicitor's certificate of service on behalf of Adrian Howard confirming service of the Responding Motion Record (Motion to Compel) upon Plaintiffs (Defendants by Counterclaim) Teva Canada Ltd. and Apotex Inc. by personal service on 02-MAR-2012 filed on 02-MAR-2012
Motion Record in response to Motion Doc. No. 155 containing the following original document(s): 165 Number of copies received: 3 on behalf of Defendant (Plaintiff by Counterclaim) filed on 02-MAR-2012
Written Representations contained within a Motion Record on behalf of Defendant (Plaintiff by Counterclaim) concerning Motion Doc. No. 155 filed on 02-MAR-2012
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc.163 upon all parties by email on 01-MAR-2012 filed on 02-MAR-2012
Amended Motion Record of Doc.146 (PUBLIC copy of written reps added: DOC.162) filed on 02-MAR-2012
Written Representations (re-filed as PUBLIC version in support of Motion Doc.91) contained within a Motion Record on behalf of NOVARTIS concerning Motion Doc. No. 91 filed on 02-MAR-2012
Acknowledgment of Receipt received from all parties via email with respect to doc.161 placed on file on 01-MAR-2012
Order dated 29-FEB-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 91 Result: Re: "Des Islet" motion heard in Toronto on November 9, 2012 1. With respect to the questions that Teva is ordered to answer, answers in writing shall be provided by a date to be agreed upon by the parties. 2. The parties shall agree to a date on which Teva's corporate representative will re-attend for a second round examination for discovery. Filed on 29-FEB-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1150 page(s) 245 - 253 Interlocutory Decision
Ottawa 29-FEB-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 144 on behalf of NOVARTIS compelling TEVA to provide answers to questions not answered during the examination for discovery of Dr. Mathi Mathivanan Result of Hearing: Matter partially granted held in Court Senior Usher: Cooper, B. Duration per day: 29-FEB-2012 from 09:45 to 12:45 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 3h Appearances: John Norman/Adrian Howard 613-783-8848 representing NOVARTIS Andrew Skodyn 416-360-6336 representing TEVA Draft Decision to be submitted by NOVARTIS by March 5, 2012 Comments: Counsel for Novartis is to provide public copies of their written representations (Re: Doc.144) by March 5, 2012. Parties are to advise the Court by March 5, 2012 as to how they would like to proceed with the motion to compel currently set down for March 7 and 8, 2012(p.m.) in Toronto, whether it be by teleconference or in person, or in the alternative provide new dates. Minutes of Hearing entered in Vol. 858 page(s) 224 - 235 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of Andrew Skodyn confirming service of doc 158 and 159 upon Defendant plaintiff by counter claim by personal service on 21-FEB-2012 filed on 21-FEB-2012
Sealed envelope pursuant to Protective Order dated 13-dec-2013 on behalf of Plaintiff purporting to contain Volume 2 of motion record 158 Filed on 21-FEB-2012
Motion Record containing the following original document(s): 155 156 157 Number of copies received: 3 on behalf of Plaintiff filed on 21-FEB-2012
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 155 filed on 21-FEB-2012
Affidavit of Anna Hucman sworn on 21-FEB-2012 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 155 with Exhibits A-D filed on 21-FEB-2012
Notice of Motion contained within a Motion Record on behalf of Plaintiff to Be before, Prothonotary Tabib, on March 7th or 8th 2012 as directed. for an Order compelling Novartis representative to reattend for discovery. filed on 21-FEB-2012
Solicitor's certificate of service on behalf of Andrew Skodyn confirming service of doc 152 and 153 upon Novartis Defendant/Plaintiff by counter claim by personal service on 21-FEB-2012 filed on 21-FEB-2012
Sealed envelope pursuant to protective Order dated 13th dec 2011 on behalf of Teva Canada Limited Plaintiff/Defendant to counterclaim purporting to contain Volume 2 of motion doc 152 Filed on 21-FEB-2012
Motion Record in response to Motion Doc. No. 144 containing the following original document(s): 150 151 Number of copies received: 3 on behalf of Plaintiff/Defendant by Counter Claim filed on 21-FEB-2012
Written Representations contained within a Motion Record on behalf of Plaintiff/Defendant by Counterclaim concerning Motion Doc. No. 144 filed on 21-FEB-2012
Affidavit of Anna Hucman sworn on 17-FEB-2012 contained within a Motion Record on behalf of Plaintiff/Defendant by counter cliam in opposition to Motion Doc. No. 144 with Exhibits a filed on 21-FEB-2012
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Book of Authorities upon all parties by courier on 10-FEB-2012 filed on 13-FEB-2012
Book of Authorities consisting of 1 volume(s) on behalf of Defendant (Plaintiff by Counterclaim) received on 13-FEB-2012
Letter from NOVARTIS dated 13-FEB-2012 Please accept this letter as confirmation that Novartis does not intend to proceed with the motion to compel Apotex currently set for hearing on February 29, 2012. (scanned) received on 13-FEB-2012
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of doc.146,147 and Pleadings Brief upon all parties by personal service on 10-FEB-2012 filed on 10-FEB-2012
PLEADINGS BRIEF in support of Motion Doc.145 on behalf of NOVARTIS received on 10-FEB-2012
Sealed envelope pursuant to Confidentiality Order issued December 13, 2011 on behalf of TEVA purporting to contain CONFIDENTIAL written representations and exhibits of Affidavit of Erin McIntomny-Exh.A,B,C,D,E,G,H (doc.146) in support of motion doc. 145 (2 VOLUMES) Filed on 10-FEB-2012
Motion Record containing the following original document(s): 144 145 Number of copies received: 3 on behalf of Novartis (PUBLIC VERSION) filed on 10-FEB-2012
Affidavit of Erin McIntomny sworn on 09-FEB-2012 on behalf of TEVA in support of Motion Doc. No. 144 with Exhibits A,B,C,D,E,G,H confidential; F is public filed on 10-FEB-2012
Notice of Motion (PUBLIC VERSION) contained within a Motion Record on behalf of Defendant returnable at Special Sitting in Ottawa on 29-FEB-2012 to begin at 09:30 for an Order requiring TEVA to provide answers to questions not answered during the examination for discovery of Teva held November 22, 2011. filed on 10-FEB-2012
Communication to the Court from the Registry dated 07-FEB-2012 re: Letters from Novartis and Teva dated February 6 and 7, 2012 concerning the parties disagreement regarding the draft order for the "Des Islet" motion to compel. (Sent by email)
Letter from Teva dated 07-FEB-2012 in response to Novartis' letter of February 6, 2012. As stated by counsel for Novartis, there remains one outstanding item in dispute between the parties, namely item #94 from the draft order...We respectfully submit that this disagreement centres entirely on Novartis' unreasonable interpretation of the question at item #94 and the Court's ruling...In light of the above, we respectfully request that the draft Des Islet Order issue without item #94. received on 07-FEB-2012
Letter from Novartis dated 06-FEB-2012 While it is our understanding that it was Teva's responsibility to provide the draft order to the Court, in an effort to have this matter resolved, we provide the same. Although Teva provided us with its draft Order, there may still be an outstanding issue with respect to the final wording for rulings to questions 908,911,912 and 913...It is Novartis position that the draft order must include the ruling of the Court. We send this draft in an effort to have the Order finalized before any second round motions to compel must be filed. (Draft Order re: Motion to compel "Des Islet" attached) received on 06-FEB-2012
Sealed envelope pursuant to Protective Order dated December 13, 2011 on behalf of Teva Canada Ltd. purporting to contain Mediation Memorandum (Commercial Implications) Filed on 19-DEC-2011
Acknowledgment of Receipt received from All parties with respect to Docs. #140, 141 & 142 (Orders from Tabib, P. dated January 18, 2012). placed on file on 19-JAN-2012
Order dated 18-JAN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The second round of examinations on discovery of Novartis' representative will be completed on January 25, 2012. 2. Novartis shall provide answers to the remaining undertakings of the first round of its discovery and to the first 2 days of the second round by February 3, 2012. 3. Novartis shall provide answers to undertakings given during the attendance of January 25, 2012 by February 10, 2012. 4. Apotex's answers to undertakings given during the second round of its discovery shall be provided by February 3, 2012. 5. Novartis shall serve and file its full motion records on any motions for refusals arising out of its discovery of Teva and Apotex no later than February 10, 2012. Such motion will be made returnable at a Special Sitting on February 29, 2012 in Ottawa beginning at 9:30 a.m. for motions arising out of the discovery of Teva and at 1 p.m. for the motions arising out of the discovery of Apotex. 6. The responding records of Teva and Apotex shall be served and filed no later than February 21, 2012. 7. Teva and Apotex shall serve and file full motion records on any motions to compel arising out of the second round of their examination on discovery of Novartis no later than February 21, 2012. Such motions shall be heard at a Special Sitting in Toronto either in the afternoon of March 7, 2012 or on March 8, 2012, as may be directed by the Court. 8. Novartis' responding records to Teva and Apotex¿s motion shall be served and filed no later than March 2, 2012. 9. All parties' expert reports in chief shall be served and filed, as pre- trial conference materials, no later than March 30, 2012. 10. Teva and Apotex shall serve and file their pre-trial conference memoranda no later than June 1, 2012. 11. All parties' responding expert reports shall be served and filed, as pre-trial conference materials, no later than June 15, 2012. 12. Novartis' pre-trial conference memorandum shall be served and filed no later than June 15, 2012. 13. The pre-trial conference in this matter shall be held beginning at 10:00 a.m. on June 20, 2012, by telephone conference, for a duration of 2 hours. 14. With the exception of documents or information on which litigation or solicitor-client privilege is claimed, and scientific literature in the public domain, no party may validly produce documents or provide information in answer or supplementary answer to discovery questions for the purposes of Rules 232 and 248 without the consent of the other party or leave of the Court after March 15, 2012. 15. All parties having confirmed that they have not conducted tests for the purposes of this litigation and do not contemplate conducting tests for the purposes of their expert reports in chief, any party intending to conduct tests or experiments for the purposes of their responding expert reports are to advise the other party at least 30 days prior to the tests or experiments being conducted and afford the other parties a reasonable opportunity to attend. Filed on 18-JAN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1146 page(s) 138 - 141 Interlocutory Decision
Order dated 18-JAN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 109 Result: 1. With respect to the questions Novartis has agreed or is ordered to answer (as set out above), answers in writing shall be provided by December 9, 2011. 2. The parties shall agree to a date on which Novartis' corporate representative, will re-attend for a second round examination for discovery. Filed on 18-JAN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1146 page(s) 126 - 137 Interlocutory Decision
Order dated 18-JAN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 113 Result: 1. With respect to the questions Dr. Zimmerman has agreed or is ordered to answer (as set out above), answers in writing shall be provided by December 9, 2011. [See Order re: Chart] Filed on 18-JAN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1146 page(s) 121 - 125 Interlocutory Decision
Ottawa 17-JAN-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss draft orders provided by counsel regarding the "Zimmerman" and "Waibel" motions to compel which are disputed by both parties;and modifying the current timetable. Result of Hearing: The Court shall issue the parties proposed draft Orders as submitted with the changes agreed upon by counsel to be reflected; A revised scheduling Order will also issue. held in chambers by way of Conference Call Duration per day: 17-JAN-2012 from 10:00 to 11:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1h25min Appearances: A. Skodyn/A. McIntyre 416-360-3498 representing Teva Canada Ltd. D. Cappe 416-849-6901 representing Apotex Inc. A. Creber/J. Norman/J. Wilkie 613-786-0140 representing Novartis Minutes of Hearing entered in Vol. 855 page(s) 372 - 383 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 16-JAN-2012 directing that A case management teleconference conference will be held on January 17, 2012 at 10:00a.m. placed on file on 16-JAN-2012 Confirmed in writing to the party(ies)
Letter from TEVA dated 10-JAN-2012 requesting a case management conference to be scheduled to discuss the remaining steps in these actions....Given the fact that certain dates in the existing schedule have been superseded, and the likelihood that further discovery is required, the current schedule needs to be modified...Counsel for Teva and Apotex are generally available over the next 2 weeks. (scanned) received on 11-JAN-2012
Communication to the Court from the Registry dated 05-JAN-2012 re: Letters from counsel dated December 22 and 23, 2011 with attached proposed draft orders concerning the "Waibel" and "Zimmerman" motions to compel. Parties are not in agreement with the form and content of the draft orders.
Letter from Novartis AG dated 23-DEC-2011 in response to the letter from Apotex dated December 22, 2011. As the following shows, Apotex unsolicited letter is not based on a substantive complaint but an attempt to secure a procedural windfall to which it is not entitled...As the above shows, the facts do not support Apotex' inference that Novartis is intentionally withholding discovery answers or documents... Finally, Novartis disagrees that Apotex and Teva are permitted to force Dr. Zimmerman and Novartis AG to waive their rights...Subsequently, Apotex and Teva changed their positions. They now want Dr. Zimmerman and Novartis AG to waie their rights...As such, we request that the order not include the sentence that would required Dr. Zimmerman and Novartis AG to waive their rights. received on 23-DEC-2011
Toronto 20-DEC-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Mediation Result of Hearing: Matter not settled held in Court Senior Usher: Ron Bradley Duration per day: 20-DEC-2011 from 09:30 to 01:30 Courtroom : Discovery Room No. 4-45 - Toronto Court Registrar: Vanessa George Total Duration: 4h Appearances: Mr. Jonathan Stainsby 416-360-6336 representing Plaintiff (Teva) Mr.Andrew Skodyn 416-360-6336 representing Plaintiff (Teva) Mr. Andrew Brodkin 416-979-2211 representing Plaintiff (Apotex) Mr.Daniel Cappe 416-979-2211 representing Plaintiff (Apotex) Mr.Anthony Creber 613-786-0140 representing Defendant (Novartis) Comments: Heard together with T-833-11. Matter has not settled. Minutes of Hearing entered in Vol. 855 page(s) 7 - 8 Abstract of Hearing placed on file
Letter from Apotex dated 22-DEC-2011 and on behalf of Teva Canada Ltd. The parties have been unable to agree on a form of order from the refusals motions flowing from the examinations for discovery of Mr. Waibel and Dr. Zimmerman. Please find attached proposed draft ordres from each motion. We have indicated those areas where the parties disagree by underlining Apotex and Teva's proposed additions to Novartis' proposed draft order...Accordingly, Apotex and Teva respectfully submit that the attached Orders ought to be finalized as soon as possible, as it appears that it might be necessary for Apotex and /or Teva to bring a motion for relief in this regard. received on 22-DEC-2011
Sealed envelope pursuant to Order dated 18-Oct-2011 on behalf of Plaintiff purporting to contain Mediation Memorandum Filed on 19-DEC-2011
Solicitor's certificate of service on behalf of Isabel Jean Raasch confirming service of doc.137 upon Teva and Apotex by personal service on 19-DEC-2011 filed on 19-DEC-2011
Mediation Brief on behalf of Novartis AG filed on 19-DEC-2011
Amended PROTECTIVE ORDER (granting motion doc.130) rendered on 13-DEC-2011 by Mireille Tabib, Prothonotary filed on 13-DEC-2011 Matter considered without personal appearance amending DOC.89 filed October 18, 2011 entered in J. & O. Book, volume 1143 page(s) 253 - 266 Interlocutory Decision certified copies sent to parties Transmittal letters placed on file.
Communication to the Court from the Registry dated 06-DEC-2011 re: Motion to amend the protective order, on consent
Letter from Defendant dated 05-DEC-2011 Further to the CMC on November 30, 2011, 2011, wherein the amendments proposed to the Protective Order were discussed and the parties indicated their consent to the form of order. received on 05-DEC-2011
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of doc. no. 134 upon Teva Canada Limited and Apotex Inc. by electronically, on consent on 05-DEC-2011 filed on 05-DEC-2011
Motion Record containing the following original document(s): 130 131 132 133 Number of copies received: 2 on behalf of Defendant filed on 05-DEC-2011
Affidavit of Dr. Andreas Länzlinger sworn on 30-NOV-2011 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 130 with Exhibits A-E filed on 05-DEC-2011
Sealed envelope pursuant to Protective and Confidentiality Orders dated October 18 and 19, 2011 on behalf of Defendant purporting to contain Affidavit of Peter Roth, sworn on November 29, 2011, with exhibits A-E Filed on 05-DEC-2011
Consent on behalf of all parties to the Protective Order set out at Schedule "B" filed on 05-DEC-2011
Notice of Motion contained within a Motion Record on behalf of Defendant in writing to be placed before the Court in Ottawa for an Order 1. amending the protective orders issued on October 18 in T-2021-10 and T-679-11 and October 19, 2011 in T-833-11 and T-599-11 in these proceedings protecting and maintaining the confidentiality of certain documents, information and transcripts to be produced by the parties during the course of these proceedings in accordance with the draft Orders attached hereto as Schedule « A » and Schedule « B ». filed on 05-DEC-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 30-NOV-2011 directing that Mediation briefs are to be served and filed by no later than 10:30a.m. on December 19, 2011. Each party is also to file by the same deadline, for the Court's eyes only, a supplementary mediation brief containing financial and/or commercial information that may be of assistance to the Court for the purposes of the Dispute Resolution Conference. The parties are to advise the Court as to: the issuance of a consent amended protective Order, and draft Order arising out of the motions to compel; The parties are to discuss and attempt to agree on revisions to the last scheduling Order, taking into account changes already agreed as to reattendance and adjustments to the next steps. placed on file on 30-NOV-2011 Confirmed in writing to the party(ies)
Ottawa 30-NOV-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: to discuss scheduling; draft orders concerning the motions to compel and the upcoming mediation on December 20, 2011. A Direction will issue. (heard together with T-833-11; minutes taken in T-2021-10) held in chambers by way of Conference Call Duration per day: 30-NOV-2011 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 35min Appearances: Andrew Skodyn/Andrew McIntyre 416-643-6930 representing TEVA John Norman/Anthony Creber/Isabel Jean-Raasch 613-786-0140 representing NOVARTIS Daniel Cappe/Dino Clarizio 416-597-4140 representing APOTEX Minutes of Hearing entered in Vol. 853 page(s) 345 - 351 Abstract of Hearing placed on file
Letter from NOVARTIS dated 29-NOV-2011 In anticipation of the items to discuss during the case management call scheduled for tomorrow at 10:00, we wish to advise the Court of the following items in which progress has been made: (see letter for details) A copy of the agreed amended Protective Order is enclosed. (scanned) received on 29-NOV-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 24-NOV-2011 directing that "A case management teleconference is scheduled for November 30, 2011 at 10:00a.m." placed on file on 24-NOV-2011 Confirmed in writing to the party(ies)
Letter from Defendant dated 21-NOV-2011 providing the parties' mutual dates of availability for a case management conference, as requested by the Court at the conclusion of the Hearing on 17-NOV-2011 received on 21-NOV-2011
Ottawa 17-NOV-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Motion Doc. No. 109 on behalf of Teva/Apotex Re: Motion to compel against Novartis (Examination of "Waibel"). Originally heard on November 7, 2011. Heard together with T-833-11. Result of Hearing: Matter partially granted held in Court Senior Usher: Sean Young Duration per day: 17-NOV-2011 from 10:40 to 02:35 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 3h55min Appearances: John Norman/Isabel Jean Raasch/Anthony Creber 613-283-1781 representing NOVARTIS Andrew McIntyre 416-360-6336 representing TEVA Daniel Cappe 416-979-2211 representing APOTEX Comments: The Court will hold a Mediation on December 20, 2011 at 9:30a.m. for 1 day in Toronto. The parties' authorized representatives are to attend. Mr. Norman will submit a draft order with regards to the motion heard today after consultation with opposing counsel. Counsel will also provide written representations as to a proposed schedule and mutual dates of availablity for a case management telephone conference. Minutes of Hearing entered in Vol. 852 page(s) 477 - 496 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-NOV-2011 directing that RE: Resumption of the "Waibel" motion to compel "The motion will be heard beginning at 10:30a.m. on November 17, 2011, for a duration not exceeding one day." placed on file on 14-NOV-2011 Confirmed in writing to the party(ies)
Letter from Daniel Cappy, counsel for Apotex dated 14-NOV-2011 (via email)All counsel are available to resume the previously adjourned motion concerning Mr. Waibel on Thursday, November 17th in Ottawa...If the Court is available all day, we ask that the motion commence in the morning.. to allow the parties a full day if necessary. In addition, we confirm that Apotex is available for a dispute resolution conference on December 20th in Toronto. (Scanned) received on 14-NOV-2011
Ottawa 10-NOV-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 96 on behalf of NOVARTIS Motion to compel against APOTEX (Examination of Dr. Sherman) Heard together with file T-833-11. Result of Hearing: Matter partially granted ; Order to follow held in Court Senior Usher: John Charlebois Duration per day: 10-NOV-2011 from 01:30 to 04:25 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 2h55min Appearances: John Norman 613-233-1781 representing NOVARTIS Daniel Cappe 416-979-2211 representing APOTEX INC. Comments: Counsel are to advise the Court by November 14th of joint dates of availability to resume the "Waibel" motion to compel. Counsel are also to communicate with the Court regarding possible availability for a dispute resolution conference. Minutes of Hearing entered in Vol. 852 page(s) 281 - 296 Abstract of Hearing placed on file
Toronto 09-NOV-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 91 on behalf of Defendant Result of Hearing: Matter partially granted held in Court Duration per day: 09-NOV-2011 from 09:45 to 12:25 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jena Russell Total Duration: 2h 40min Appearances: . Andrew Skodyn/ Andrew Mcintyre 416-360-3498 representing Plaintiff John Norman 613-786-8673 representing Defendant Minutes of Hearing entered in Vol. 852 page(s) 256 - 262 Abstract of Hearing placed on file
Ottawa 07-NOV-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 113 on behalf of TEVA/APOTEX Motion to compel against Novartis(Examination of Dr. Zimmerman) Result of Hearing: Matter partially granted with Order to follow Before the Court: Motion Doc. No. 109 on behalf of TEVA/APOTEX Motion to compel against Novartis (Examination of "Waibel") Result of Hearing: Matter adjourned to a date to be fixed by the Case Management Judge *Items 1 to 39 of refusals chart were dealt with at hearing out of 124 Items held in Court Senior Usher: John Charlebois Duration per day: 07-NOV-2011 from 09:30 to 04:30 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 7h Appearances: Andrew Skodyn/Andrew McIntyre 416-360-6336 representing TEVA Daniel Cappe 416-979-2211 representing APOTEX INC. John Norman/Isabel Jean Raasch 613-233-1781 representing NOVARTIS Comments: Loose authority provided by Apotex Inc. (A-390-09, rendered 2-NOV-2011) Parties are required to obtain instructions from their clients regarding mediation, who would participate and their availabilities by November 9th. (Apotex can advise the Court on November 10th) The Court also aske the parties to work out a schedule to hear the continuation of the the "Waibel" motion (doc. 109) and a possible mediation by November 9th. Minutes of Hearing entered in Vol. 852 page(s) 167 - 191 Abstract of Hearing placed on file
Covering letter from TEVA dated 03-NOV-2011 concerning the "Pleadings Brief" placed on file on 04-NOV-2011
PLEADINGS BRIEF (Re: Motions to compel being heard in Ottawa and Toronto November 7, 9 and 10) submitted by counsel for TEVA. received on 04-NOV-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 31-OCT-2011 directing that "The hearing of November 1 and 2 is adjourned as follows: Teva and Apotex's motions (Doc. 109 and 113) will be heard in Ottawa beginning at 9:30 a.m. on November 7, 2011 for a full day. Novartis' motion against Teva (Doc. 91) will be heard in Toronto beginning at 9:30a.m. on November 9, 2011 for a duration of half a day. Novartis' motion against Apotex(Doc.96) will be heard in Ottawa beginning at 1:30p.m. on November 10, 2011 for a duration of half a day." placed on file on 31-OCT-2011 Confirmed in writing to the party(ies)
Ottawa 31-OCT-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the adjournment of the motions to compel scheduled on November 1 and 2, 2011 in Toronto. (Motion Docs. 91, 96, 109, 113) Heard together with T-833-11. Result of Hearing: Motions adjourned to new dates in Ottawa and Toronto. Directions to follow. held in chambers by way of Conference Call Duration per day: 31-OCT-2011 from 01:30 to 01:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 20min Appearances: Andrew Skodyn/Andrew McIntyre 416-360-3498 representing TEVA Jennifer Wilkie/Isabel Raasch 613-786-0156 representing NOVARTIS Daniel Cappe 416-849-6901 representing APOTEX Minutes of Hearing entered in Vol. 851 page(s) 462 - 465 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 31-OCT-2011 directing that A case management teleconference will take place today, October 31, 2011 at 1:30p.m. placed on file on 31-OCT-2011 Confirmed in writing to the party(ies)
Letter from APOTEX (by email) dated 31-OCT-2011 Apotex agrees with Teva's position with regards to the adjournment. (scanned) received on 31-OCT-2011
Letter from TEVA (by email) dated 31-OCT-2011 Teva does not object to the adjournment request in principle. Our only concern is that any adjournment not cause a material alteration to the overall schedule or have any potential effect on the trial date... received on 31-OCT-2011
Letter from NOVARTIS (by email) dated 31-OCT-2011 seeking an adjournment of the motion to compel hearings scheduled for November 1 and 2, 2011 in Toronto to be set at a later date. (scanned) received on 31-OCT-2011
Letter from Novartis dated 27-OCT-2011 ...we confirm that counsel for all parties has agreed to hand-amend their copies of the Motion to Compel of Novartis (Doc.94-Examination of Des Islet) We note that the only change being made is to move confidential information from Tabs 8 and 9 into the confidential Volume 2. (scanned) received on 27-OCT-2011
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Authorities of Novartis upon Teva and Apotex by courier on 27-OCT-2011 filed on 27-OCT-2011
Book of Authorities consisting of 1 volume(s) on behalf of NOVARTIS in support of motion to compel (Doc.109), Examination of Waibel received on 27-OCT-2011 Sent directly to Presiding Judge
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Novartis' Authorities upon Apotex and Teva by courier on 27-OCT-2011 filed on 27-OCT-2011
Book of Authorities consisting of 1 volume(s) on behalf of NOVARTIS in support of motion to compel(Doc.113),Examination of Zimmerman received on 27-OCT-2011 Sent directly to Presiding Judge
Letter from APOTEX (Via email) dated 27-OCT-2011 writing further to Mr.Stainsby's email below and the Court's direction dated Oct. 26. Apotex agrees with Teva's position, namely that the primary concern is with the affidavit's (Mr. Roth) substance rather than its form. Specifically, Apotex does not object to the filing of the unsworn affidavit so long as the properly sworn affidavit is delivered prior to the hearing of the matter...Apotex also asks that the Direction of October 26, 2011 and any future direction concerning this issue be issued (or re-issued in T-833-11 as well as T-2021-10. (scanned) received on 27-OCT-2011
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of doc.99, version 2 (see Direction dated October 26, 2011) upon Apotex by courier on 25-OCT-2011 filed on 26-OCT-2011
Letter from TEVA dated 26-OCT-2011 (By e-mail) in response to the correspondence sent by Novartis in this action and in response to the Direction of October 26, 2011 (Re: Novartis' motion containing the un-commissioned affidavit of Peter Roth) Teva does not object to the filing of the Roth affidavit...provided that a sworn copy is untimately produced...Teva has serious concerns about this affidavit...These concerns which Teva will raise in support of its position that the affidavit ought to be struck, or at least, given no weight, will not change whether the affidavit is sworn or remains unsworn. (scanned) received on 26-OCT-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 26-OCT-2011 directing that RE: Novartis motion to comepl filed october 19th (Doc.99) "Novartis has leave to remove from the Court record the copies of document 99 originally filed on October 19, 2011. The revised copy of this motion record submitted for filing on October 26, 2011 shall be received for filing in its stead." placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)
Letter from NOVARTIS dated 26-OCT-2011 We write further to the motion record (motion to compel) of Novartis filed Oct. 19th (Doc.99) It has come to our attention that the nature of the document located at Tab 13 is confidential, but was mistakenly filed without proper seal...please find enclosed an amended set of motion records to reflect the confidential nature of TAB 13. No changes to the content of the motion record have been made...(scanned) received on 26-OCT-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 26-OCT-2011 directing that Re: Novartis' request to replace their motion record filed October 19th (Doc. 94) with an amended version "Novartis has leave to remove from the Court record the copies of document 94 originally filed on October 19, 2011. The Revised copy of the motion record submitted for filing on October 25, 2011 shall be received for filing in its stead." placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)
Letter from NOVARTIS dated 25-OCT-2011 further to our letter of October 21, 2011 please find enclosed an amended set of Motion Records of Novartis...We request that the original set of motion records filed Oct. 19, 2011 be destroyed...(scanned) received on 26-OCT-2011
Letter from NOVARTIS dated 25-OCT-2011 We write further to the October 24, 2011 filing of Novartis' responding motion record to Apotex and Teva's motion to compel answers arising from discovery of Mr. Waibel. Novartis' responding record included the signed but un-commissioned affidavit of Mr. Peter Roth...Mr. Roth has not been able to swear his affidavit due to difficulties in obtaining access to a commissioner for oaths in Switzerland...he will be swearing the affidavit next week. As such we respectfully request that the Court accept the signed unsworn affidavit for filing at this time. (scanned) received on 25-OCT-2011
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of doc.125 upon all parties by personal service on 24-OCT-2011 filed on 26-OCT-2011
Motion Record in response to Motion Doc. No. 109 containing the following original document(s): 122 123 124 Number of copies received: 3 on behalf of NOVARTIS filed on 26-OCT-2011
Sealed envelope pursuant to Protective and Confidentiality Orders dated 18-OCT-2011 on behalf of NOVARTIS purporting to contain Refusals chart (Re: Motion Doc. 109) Filed on 26-OCT-2011
Written Representations contained within a Motion Record on behalf of Novartis concerning Motion Doc. No. 109 filed on 26-OCT-2011
Affidavit of Peter R. Roth (un-commissioned-See Direction dated 26-OCT-2011) on behalf of NOVARTIS, contained in the Responding motion record of Novartis. Regarding motion doc. 109 filed on 26-OCT-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 26-OCT-2011 directing that RE: Novartis and Teva's responding motion record submitted on October 25th with the signed but un-commissioned affidavit of Mr. Peter Roth. Counsel are seeking leave to file the responding record as produced at this time. "Accept for filing subject to any objection by the Plaintiffs." placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of doc.120 upon Apotex and Teva by personal service on 24-OCT-2011 filed on 24-OCT-2011
Motion Record in response to Motion Doc. No. 113 containing the following original document(s): 118 119 Number of copies received: 3 on behalf of NOVARTIS filed on 24-OCT-2011
Sealed envelope pursuant to Confidential and Protective Orders dated 19-OCT-11 on behalf of NOVARTIS purporting to contain Refusals chart Re: Motion to Compel (Doc. 113) Filed on 24-OCT-2011
Written Representations contained within a Motion Record on behalf of NOVARTIS concerning Motion Doc. No. 113 filed on 24-OCT-2011
Solicitor's certificate of service on behalf of Daniel Cappe confirming service of DOC 116 upon all parties by e-mail on 14-OCT-2011 filed on 19-OCT-2011
Motion Record containing the following original document(s): 113 114 115 Number of copies received: 3 on behalf of Apotex Inc & Teva Canada Ltd filed on 19-OCT-2011
Written Representations contained within a Motion Record on behalf of Apotex Inc and Teva Canada Ltd concerning Motion Doc. No. 113 filed on 19-OCT-2011
Affidavit of Nicole Roth sworn on 13-OCT-2011 on behalf of Apotex Inc & Teva Canada Ltd in support of Motion Doc. No. 113 with Exhibits A-G filed on 19-OCT-2011
Notice of Motion contained within a Motion Record on behalf of Apotex Inc & Teva Canada Ltd returnable at Special Sitting in Toronto on 01-NOV-2011 to begin at 09:30 for an Order compelling Dr. J. Zimmerman to re-attend for examination for discovery and provide answers to certain questions refused at the examinations held on 23-AUG-2011. filed on 19-OCT-2011
Solicitor's certificate of service on behalf of Apotex confirming service of doc.111 upon Defendant by email on 24-OCT-2011 filed on 24-OCT-2011
Motion Record in response to Motion Doc. No. 96 containing the following original document(s): 110 Number of copies received: 3 on behalf of plaintiff,Apotex filed on 24-OCT-2011
Written Representations (partially Sealed envelope) contained within a Motion Record on behalf of Plaintiff,Apotex concerning Motion Doc. No. 96 filed on 24-OCT-2011
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Toronto on 01-NOV-2011 to begin at 09:30 for Motion to Compel Answers (Sealed pursuant to Confidentiality Order) re: Discovery of Peter Waibel (contained within Doc 101) filed on 19-OCT-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 24-OCT-2011 directing that RE: Novartis letter dated October 21st requesting that volume 1 of their motion to compel (Doc.94) be treated as confidential "Please keep the identified volume as confidential" placed on file on 24-OCT-2011 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 24-OCT-2011 This letter states that Teva is submitting a motion record, and that the second volume is confidential. received on 24-OCT-2011
Solicitor's certificate of service on behalf of Andrew Skodyn confirming service of Doc 106, 107 upon Defendant by overnight courier on 21-OCT-2011 filed on 24-OCT-2011
Motion Record in response to Motion Doc. No. 91 containing the following original document(s): 104 105 Number of copies received: 3 on behalf of Plaintiff filed on 24-OCT-2011
Sealed envelope pursuant to Confidentiality Order dated 18-OCT-2011 on behalf of Plaintiff purporting to contain The Responding Motion Record of Teva Canada (Vol 2 of 2) Filed on 24-OCT-2011
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 91 filed on 24-OCT-2011
Affidavit of Anna Hucman sworn on 21-OCT-2011 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 91 with Exhibits A filed on 24-OCT-2011
Communication to the Court from the Registry dated 21-OCT-2011 re: Letter from Novartis dated Oct. 21. regarding confidential material placed in the public motion record.
Letter from Novartis dated 21-OCT-2011 Regarding Novartis' Motion to compel that was filed Oct. 14, 2011 (Doc.94) we have been advised by counsel for Teva that there is information in the non-confidential motion record that should be treated as confidential. (Vol 1). We will serve and file a revised set of motion records early next week withthe confidential information re-located into the confidential volume. (scanned) received on 21-OCT-2011
Solicitor's certificate of service on behalf of ANDREW MCINTYRE confirming service of DOC 101, 102, BOOK OF AUTHORITIES upon Defendant by courier on 14-OCT-2011 filed on 19-OCT-2011
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 19-OCT-2011
Sealed envelope pursuant to Confidentiality Order dated 18-OCT-2011 on behalf of Plaintiff purporting to contain Brief of Transcript from the discovery of Peter Waibel Filed on 19-OCT-2011
Sealed envelope pursuant to Confidentiality Order dated 18-OCT-2011 on behalf of Plaintiff purporting to contain Motion Record (Doc #109) to compel answers to questions refused by the Defendant Filed on 19-OCT-2011
Acknowledgment of Receipt received from all parties via email with respect to 89 and 90 placed on file on 18-OCT-2011
Solicitor's certificate of service on behalf of Isabel Raasch confirming service of doc. 99 upon all parties by personal service on 14-OCT-2011 filed on 19-OCT-2011
Motion Record containing the following original document(s): 96 97 98 Number of copies received: 3 on behalf of NOVARTIS (2 Volumes. VOL. 2 is CONFIDENTIAL) filed on 19-OCT-2011
Written Representations contained within a Motion Record on behalf of Novartis concerning Motion Doc. No. 96 filed on 19-OCT-2011
Affidavit of Erin McIntomny sworn on 13-OCT-2011 contained within a Motion Record on behalf of Novartis in support of Motion Doc. No. 96 with Exhibits "A" to "H" **Exhibits "G" an "H" are CONFIDENTIAL filed on 19-OCT-2011
Notice of Motion contained within a Motion Record on behalf of Novartis (2 Volumes; Volume 2 is CONFIDENTIAL. See Direction 26-OCT-2011) returnable at Special Sitting in Toronto on 01-NOV-2011 to begin at 09:30 for an Order requiring APOTEX to provide answers to questions not answered during the examination for discovery of Apotex held August 29, 2011 (SHERMAN) this motion. filed on 19-OCT-2011
Solicitor's certificate of service on behalf of Isabel Raasch confirming service of doc.94 upon all parties by personal service on 14-OCT-2011 filed on 19-OCT-2011
Motion Record containing the following original document(s): 91 92 93 Number of copies received: 3 on behalf of Novartis (VOL. 2 SEALED. SEE Direction dated OCT. 26, 2011) filed on 19-OCT-2011
Written Representations contained within a Motion Record on behalf of Novartis concerning Motion Doc. No. 91 filed on 19-OCT-2011
Affidavit of Marcail Delahunt sworn on 13-OCT-2011 contained within a Motion Record on behalf of Novartis in support of Motion Doc. No. 91 with Exhibits "A" to "I" (Exhibits "H" and "I" are CONFIDENTIAL) filed on 19-OCT-2011
Notice of Motion contained within a Motion Record on behalf of Novartis returnable at Special Sitting in Toronto on 01-NOV-2011 to begin at 09:30 for an Order requiring Teva Canada Ltd. to provide answers to questions not answered during the examination for discovery of TEVA(Des Islet)held August 31,2011. 2. Novartis' costs of this motion. filed on 19-OCT-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 19-OCT-2011 directing that RE: Motions to compel being heard in Toronto on November 1 and 2, 2011 "All 4 motion records received on October 14, 2011 are to be filed as of today in file T-2021-10." placed on file on 19-OCT-2011 Confirmed in writing to the party(ies)
CONFIDENTIALITY ORDER dated 18-OCT-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1.Where in support of a motion to compel further or better answers to undertakings given on discovery, or to rule on objections made on discoveries...the exhibits, documentary productions, transcripts and refusals charts may be segregated from the other motion materials and be filed in sealed envelopes, and the material shall be treated as confidential without the need for a further motion or order pursuant to Rule 151... 2...In any event, the terms of this Order do not apply to the hearing of the action or counterclaim on their merits in which final judgment and reasons for judgment are to written and treated, unless specifically ordered by the trial Judge. 3...(SEE LINK or FILE for further details of Order) Filed on 18-OCT-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1138 page(s) 48 - 50 Interlocutory Decision
PROTECTIVE ORDER dated 18-OCT-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: granted Filed on 18-OCT-2011 certified copies sent to parties (Protective Order rendered in T-2021-10 and T-679-11) Transmittal Letters placed on file. entered in J. & O. Book, volume 1138 page(s) 34 - 47 Interlocutory Decision
Solicitor's certificate of service on behalf of Isabel Raasch confirming service of Book of Authorities pertaining to the motion to compel of Novartis upon Plaintiff (defendant by counterclaim) and Respondent Minister of Health by courier on 17-OCT-2011 filed on 18-OCT-2011
Book of Authorities consisting of 1 volume(s) on behalf of Defendant (plaintiff by counterclaim) received on 18-OCT-2011 Sent directly to Presiding Judge
Letter from counsel for Teva Cda. Ltd. dated 13-OCT-2011 with the attached Protective Order agreed to by counsel for Teva Cda. and Novartis in T-2021-10, further to the case management teleconference held yesterday. (scanned) received on 13-OCT-2011
Acknowledgment of Receipt received from all parties via email with respect to doc.87 placed on file on 13-OCT-2011
Order dated 13-OCT-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The trial of this matter will take place either in Ottawa or Toronto, to be determined at the pre-trial conference, in French and English, beginning September 24, 2012 at 9:30 for a duration of a maximum of 30 days, excluding September 26, 2012, October 3,4 and 5, 2012. The duration of the trial is subject to be reduced, if appropriate, at or following the pr-trial conference to be held in this matter. The parties should note that the Court may sit 5 days a week for the trial. 2. The Plaintiff's pre-trial conference memoranda served/filed by May 10, 2012. 3. Defendant's pre-trial memorandum served/filed by May 22, 2012. 4. The PTC shall be held by teleconference at 9:30 on May 25, 2012 for 2 hours. 5. Motion records to compel answers arising out of second round of exams. for discovery served/filed by December 9, 2011. 6. Responding records served/filed by December 16, 2011 with courtesy electronic copy to the Court. 7. Motions to compel arising out of second round of discoveries shall be heard at a special sitting in Ottawa at 9:30 on December 20, 2011 for 1 day. 8...9. The parties shall report to the Court as to the progress and status of settlement discussions between them and, as the case may be, whether a dispute resolution conference would be appropriate by November 1, 2011. Filed on 13-OCT-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1137 page(s) 233 - 235 Interlocutory Decision
Ottawa 12-OCT-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss trial dates, dates for motions arising out of second round of examinations for discovery, and the possibility of settlement or the opportunity to hold a dispute resolution conference. Result of Hearing: The trial is scheduled for September 24, 2012 in Toronto or Ottawa (TBD) for 25 to 30 days; Pre-Trial Conference is scheduled for May 25, 2012 at 9:30a.m by teleconference (representatives are not required to attend) with the Plaintiff's PTC memorandum to be filed by 10-MAY-2012 and the Defendant's PTC Memoranda to be filed by 22-MAY-2012. Motions to compel arising out of the second round of discoveries, if any, are scheduled to be heard in Ottawa on December 20, 2011 at 9:30a.m. for 1 day. Moving motion records are to be filed by 9-DEC-2011, and responding motion records are to be filed by 16-DEC-2011 (with a courtesy copy of the motion and the charts send by email to the Court). held in chambers by way of Conference Call Duration per day: 12-OCT-2011 from 10:00 to 10:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 30min Appearances: Jonathan Stainsby 416-360-3568 representing Teva Jennifer Wilkie/Isabel Raasch 613-786-0156 representing Novartis Andrew Brodkin/Dino Clarizio 416-597-4278 representing Apotex Comments: A draft protective Order may be submitted by parties by the end of this week Minutes of Hearing entered in Vol. 850 page(s) 388 - 393 Abstract of Hearing placed on file
Acknowledgment of Receipt received from all parties via e-mail with respect to doc.86 placed on file on 15-SEP-2011
Letter from Plaintiff dated 23-SEP-2011 addressing issues with respect to the scheduling of the trial of this matter received on 23-SEP-2011
Order dated 13-SEP-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: The schedule set out in the Order of June 1, 2011 is modified as follows: 1...2. Motion records on any motion to compel further and better answers to undertakings or rule on objections made during discovery shall be served and filed no later than October 14, 2011; 3. Responding records on motions to compel shall be served and filed no later than october 24, 2011. 4.... 5. Motions to compel shall be heard at a special sitting in Toronto at 9:30a.m. on Nov. 1, 2011 for 2 days. 6...7. Parties shall serve and file their expert reports in chief by Feb. 17, 2012. 8. Parties shall serve and file their respective rebuttal reports by April 30, 2012. 9. A case management conference will be held Oct. 12, 2011 at 10a.m. In preparation... parties shall have discussed with their clients and taken instruction as to a possible settlement or the opportunity of holding a DRC. The issues set out in par. 9 shall also be spoken to on Oct. 12. Filed on 14-SEP-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1134 page(s) 268 - 270 Interlocutory Decision
Ottawa 13-SEP-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to fix and/or discuss: trial dates; dates for motions; dates for further steps to be taken in T-2021-10 and T-833-11 as well as any other scheduling issues. (Minutes taken in T-2021-10 only) Result of Hearing: A trial date will not be fixed at this time; A scheduling Order will issue amending the current scheduling Order dated June 1, 2011; The hearing scheduled for October 11 and 12, 2011 in Toronto has been adjourned to November 1 and 2, 2011 in Toronto to hear any motions to compel; A case management teleconference is scheduled for October 12, 2011 at 10a.m. held in chambers by way of Conference Call Duration per day: 13-SEP-2011 from 10:00 to 11:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1h15min Appearances: Bill Mayo/Andrew McIntyre 416-643-6861 representing Teva Cda. John Norman/Jennifer Wilkie 613-783-8848 representing Novartis Dino Clarizio & Daniel Cappe/Andrew Brodkin 416-597-4140/416-602-3137 representing Apotex Minutes of Hearing entered in Vol. 849 page(s) 157 - 165 Abstract of Hearing placed on file
Letter from Novartis AG dated 12-SEP-2011 This is in response to the correspondence received on Friday from counsel for Aptex and counsel for Teva. General Comments:...Availability of Transcripts:...Trial Dates:...Closing Comments:...(scanned) received on 12-SEP-2011
Copy of Apotex's letter (T-833-11) in response to the Defendant's letter dated Sept. 8, 2011. Apotex's letter submits that the defendant's letter is false and misleading. dated 09-SEP-2011 placed on file on 09-SEP-2011 Original filed on Court File No. T-833-11
Letter from the Plaintiff, Teve Canada Ltd. dated 09-SEP-2011 in response to yesterday's letter from the defendant...The Defendants have known of the Sept. 15th deadline since June 1st. Furthermore, they do, in fact, have the inventor's transcripts...As for the question of the trial date, it was Teva's understanding that the Court was going to make every effort to secure a trial date in the fall 2012 and the parties were to keep themselves available for that eventuality... received on 09-SEP-2011
Letter from Novartis AG dated 08-SEP-2011 This is further to Mr. Stainsby's letter of today's date...We confirm that the first round of discovery was conducted toward the end of August. Unfortunately, not all the transcripts have yet been received...Considering that the discovery of the inventor and Novartis lasted 5 days, we are uncertain whether or not we will be able to meet the Sept. 15 deadline to provide answers to undertakings for Novartis. Insofar as Mr. Stainsby's request for a trial date...Apotex recently advised that they were not available until May 2013 for a 10 day trial in respect to T-1267-10, which action was commenced prior to the within Court actions. received on 08-SEP-2011
Letter from the Plaintiff, Teva Canada Ltd. dated 08-SEP-2011 further to the Court Order of June 1, 2011 and in advance of the case management conference scheduled for Sept. 13, 2011...We can advise the Court that the 1st round of examinations for discovery did in fact take place by the deadline of August 31,2011....we expect that motions will be brought arising out of those examinations and that the scheduled dates of October 11 and 12, 2011 will both be required...We request that the judicial administrator be contacted prior to the Sept. 13, 2011 teleconference regarding trial dates in the fall of September 2012, so that a definite date can be set...(scanned) received on 08-SEP-2011
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of doc.84 upon Plaintiff by telecopier on 06-SEP-2011 filed on 06-SEP-2011
Amended Reply to Defence to Counterclaim filed on 06-SEP-2011
Covering letter from Plaintiff dated 26-AUG-2011 concerning Doc. Nos. 82 83 placed on file on 26-AUG-2011
Solicitor's certificate of service on behalf of Jonathan Stainsby confirming service of the Amended Reply and Defence to Counterclaim upon Defendant by telecopier on 26-AUG-2011 filed on 26-AUG-2011
Amended Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 26-AUG-2011
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc.80 upon Plaintiff by personal service on 24-AUG-2011 filed on 24-AUG-2011
TWICE AMENDED Statement of Defence and Counterclaim filed on 24-AUG-2011
Acknowledgment of Receipt received from the Plaintiff and the Defendant (by EMAIL) with respect to the Order of the Court dated 12-AUG-2011 placed on file on 12-AUG-2011
Order dated 12-AUG-2011 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 59 Result: granted in part "2. Paragraph 53, subparagraphs 114(b) to (g), and paragraphs 116 to 142 of the Amended Statement of Defence and Counterclaim of the Defendant are hereby struck. 3. The Plaintiff shall serve and file, no later than 15 days from the date of this Order, and amended Reply and Defence to Counterclaim. 4. Costs of this motion are awarded in favour of the Plaintiff." Filed on 12-AUG-2011 copies sent to parties entered in J. & O. Book, volume 1132 page(s) 29 - 38 Interlocutory Decision
Letter from the Plaintiff, Teva Canada Limited, dated 29-JUL-2011 in response to the letter from the Defendant, Novartis AG, of today's date received on 29-JUL-2011
Letter from Novartis AG dated 29-JUL-2011 It has come to our attention that the SCC issued a decision today-R v. Imperial Tobacco Canada Ltd. which is relevant to the Teva and Apotex motions to strike currently before the Court on these actions... (Scanned along with attached decision of SCC) received on 29-JUL-2011
Toronto 25-JUL-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 59 on behalf of Plaintiff Result of Hearing: Matter reserved. (Heard together with Doc 9 in T-833-11) held in Court Senior Usher: Noel Nation Duration per day: 25-JUL-2011 from 09:30 to 04:55 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Vanessa George Total Duration: 1day Appearances: Mr.Jonathan Stainsby 416-360-6336 representing Plaintiff (Teva Canada Ltd) Mr. Andy Radhakant 416-360-6336 representing Plaintiff (Teva Canada Ltd) Daniel Cappe 416-979-2211 representing Plaintiff (Apotex) Mr.John Norman 613-783-8848 representing Defendant Ms.Isabel Raasch 613-786-8673 representing Defendant Comments: Plaintiff (Teva) submits the following loose case authorities: Novopharm v. Eli Lilly 2011, Eli Lilly v. Apotex 2009, Apotex v. Wellcome Foundation 2002 and Apotex v. Syntex, 1999; also Sec 60 of the Patent Act. The parties will stand down Motion Doc 73 (filed Jul 20/11) for now and address it later should the need arise. Minutes of Hearing entered in Vol. 847 page(s) 300 - 305 Abstract of Hearing placed on file
Letter from Defendant dated 22-JUL-2011 in response to the Plaintiff's correspondence dated 21-JUL-2011 (scanned to Tabib, P.) received on 22-JUL-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 22-JUL-2011 directing that RE: Motion Doc. 73 "Novartis' motion will not be heard on Monday, but a return date will be spoken to." placed on file on 22-JUL-2011 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of John Norman confirming service of Book of Authorities (Novartis) upon Plaintiff by personal service on 21-JUL-2011 filed on 21-JUL-2011
Letter from Defendant dated 20-JUL-2011 (Cover letter re: doc. 73)...we would also like to bring to the Court's attention that the parties are still engaged in negotiations over the terms of the protective and confidentiality order for this action. Nevertheless the parties have agreed to maintain documents in confidence subject to the issuance of a protective and confidentiality order...It is respectfully submitted that the parties can address whether the docs. contained within the confidential portion of the motion record should continue to be treated as confidential during the motion... received on 20-JUL-2011
Letter from Plaintiff dated 21-JUL-2011 requesting that Novartis' motion for a further and better affidavit of documents (Doc. 73) be adjourned to a date to be fixed by the Court on Monday and that Teva not be required to respond to the motion on July 25th. (scanned) received on 21-JUL-2011
Book of Authorities consisting of 1 volume(s) on behalf of Defendant in support of motion doc. 76 received on 21-JUL-2011 Sent directly to Presiding Judge
Solicitor's certificate of service on behalf of John Norman confirming service of doc.76 upon Plaintiff by personal service on 20-JUL-2011 filed on 20-JUL-2011
Motion Record containing the following original document(s): 73 74 75 Number of copies received: 3 on behalf of Defendant (Also contains VOLUME 2 which is SEALED) filed on 20-JUL-2011
Sealed envelope pursuant to proposed protective and confidentiality Order (VOLUME 2) on behalf of Defendant purporting to contain Exhibits B and H of Affidavit of Marcail Delahunt in support of motion doc. 73 Received on 20-JUL-2011
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 73 filed on 20-JUL-2011
Affidavit of Marcail Delahunt sworn on 20-JUL-2011 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 73 with Exhibits A,C,D,E,F,G,I,J,K (Exh. B and H are CONFIDENTIAL_VOL. 2) filed on 20-JUL-2011
Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for an Order pursuant to Rules 222 and 223 requiring Teva to provide Novartis with a further and better affidavit of documents within 10 days of the Order; Novartis' costs of this motion on a solicitor-and-its-own-client basis. filed on 20-JUL-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 21-JUL-2011 directing that Re: Novartis AG's motion record (public and confidential) for a further and better affidavit of documents "Accept for filing subject to any objections or representations by Teva Canada Ltd." placed on file on 21-JUL-2011 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 21-JUL-2011 re: Receipt of Novartis AG's motion record (public & confidential versions) seeking a further and better affidavit of documents, to be heard in Toronto on July 25, 2011 requires directions. (Documents received at counter on July 20, 2011)
Solicitor's certificate of service on behalf of Adrian Howard confirming service of book of authorities upon Plaintiff by courier on 08-JUL-2011 filed on 11-JUL-2011
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 11-JUL-2011
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc. 70 upon Plaintiff by personal service on 08-JUL-2011 filed on 08-JUL-2011
Motion Record in response to Motion Doc. No. 59 containing the following original document(s): 68 69 Number of copies received: 3 on behalf of Defendant filed on 08-JUL-2011
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 59 filed on 08-JUL-2011
Affidavit of Erin McIntomny sworn on 08-JUL-2011 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 59 with Exhibits A filed on 08-JUL-2011
Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc. No. 66 upon Plaintiff by telecopier on 05-JUL-2011 filed on 05-JUL-2011
Reply to Defence to Counterclaim on behalf of Defendant with consent to extend the time for filing Filed on 05-JUL-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 28-JUN-2011 directing that Re: Defendant's request for 7 day extension of time to file their reply to defence and to counterclaims until July 5, 2011 "Extension granted as requested." placed on file on 28-JUN-2011 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 28-JUN-2011 re: Defendant's request for a 7 day extension, on consent
Letter from Defendant dated 28-JUN-2011 (VIA E-MAIL) advising the Court that Teva has consented to the request for an extension until July 5th. received on 28-JUN-2011
Letter from the Defendant, Novartis dated 27-JUN-2011 seekig a 7 day extension of time for filing their reply to defence and to counterclaims...Out of an abundance of caution, we respectfully make the same request for an extension of the schedule in the Teva proceeding. received on 27-JUN-2011
Covering letter from Plaintiff dated 22-JUN-2011 concerning Doc. Nos. 64 65 placed on file on 22-JUN-2011
Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of doc. no. 64 upon Defendant by telecopier on 22-JUN-2011 filed on 22-JUN-2011
Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 22-JUN-2011
Solicitor's certificate of service on behalf of Andy Radhakant confirming service of doc. 62 and Book of Authorities upon Defendant by Courier on 20-JUN-2011 filed on 21-JUN-2011
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 21-JUN-2011
Motion Record containing the following original document(s): 59 60 61 Number of copies received: 3 on behalf of Plaintiff filed on 21-JUN-2011
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 59 filed on 21-JUN-2011
Affidavit of Anna Hucman sworn on 20-JUN-2011 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 59 with Exhibits A-G filed on 21-JUN-2011
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Toronto on 25-JUL-2011 to begin at 09:30 for an Order pursuant to R. 221(1)(a)(b)(c)(d) and (f) of the Federal Courts Rules striking the portions of the pleadings of the Defendant's Amended Statement of Defence and Counterclaim, dated 10, jun-2011 and other such releif filed on 21-JUN-2011
Letter from Apotex Inc. dated 21-JUN-2011 in support of Mr. Stainsby's letter dated June 20, 2011...Apotex respectfully requests that the trial in these proceedings be scheduled to begin in September 2012. (scanned) received on 21-JUN-2011
Letter from TEVA Canada Ltd. dated 20-JUN-2011 respectfully requesting that the Court secure a trial date in September 2012 (scanned) received on 20-JUN-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 16-JUN-2011 directing that Re: Letter from Apotex dated June 15, 2011 "Extension granted as requested." placed on file on 16-JUN-2011 Confirmed in writing to the party(ies)
Letter from Apotex Inc. dated 15-JUN-2011 requesting an extension of time for the Plaintiffs to serve and file their respective Reply and defence to Counterclaim by June 22, 2011 on consent of all parties. (scanned) received on 15-JUN-2011
Solicitor's certificate of service on behalf of John Norman confirming service of Reply/Response to demand for particulars upon Plaintiff by personal service on 10-JUN-2011 filed on 10-JUN-2011
Reply to Demand for Particulars on behalf of Defendant received on 10-JUN-2011
Covering letter from Defendant dated 10-JUN-2011 concerning Doc. Nos. 56 57 placed on file on 10-JUN-2011
Solicitor's certificate of service on behalf of John Norman confirming service of the Amended Statement of Defence and Counterclaim upon Plaintiff by personal service on 10-JUN-2011 filed on 10-JUN-2011
Amended Statement of Defence and Counterclaim filed on 10-JUN-2011
Acknowledgment of Receipt received from all parties by e-mail on June 1 and 2, 2011 with respect to doc.55 placed on file on 02-JUN-2011
Order dated 01-JUN-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. This Order modifies and supplements the Scheduling Order of April 21, 2011. 2. Plaintiff's Reply and defence to counterclaim filed by 15-JUN-11... 3. Any motion records to strike served and filed by Plaintiffs by 21-JUN-11; 4. Defendant's reply to defence and counterclaim by 27-JUN-11; 5... 6. Responding motion records to strike filed by 8-JUL-11; 7. Motions to strike shall be heard in Toronto at 9:30 on 25-JUL-11 for 1 day; 8... 9. A case management teleconference will take place September 13, 2011 at 10:00a.m....10...11. Motion records to compel filed by 18-SEP-11; 12. Responding records to compel filed by 5-OCT-11; 13. Motion to compel to be heard in Toronto at 9:30 on 11-OCT-11 for 2 days; 14...15. The parties shall serve/file expert reports in chief by 31-JAN-12; 16. Parties rebuttal expert reports filed by 15-APR-12; Parties to remain available for a trial beginning January 28, 2013 should dates in fall 2012 not be available. Filed on 01-JUN-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1125 page(s) 160 - 163 Interlocutory Decision
Ottawa 31-MAY-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Any motions to strike shall be filed by June 21, 2011; Responding motion records are due July 8, 2011; Motion to strike, if any, shall be heard on July 25, 2011 for 1 day in Toronto. Any motions regarding objections shall be filed September 28, 2011 with responding motion records due October 5, 2011, and the Court will hear them on October 11 and 12, 2011 in Toronto. A case managment conference will be held on September 13, 2011 at 10a.m. to discuss trial dates, motions for 2nd round of discoveries and other matters. An Order will issue. held in chambers by way of Conference Call Duration per day: 31-MAY-2011 from 02:00 to 03:10 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1h10min Appearances: Jonathan Stainsby/Andrew Skodyn 416-360-3568 representing Teva Canada Ltd. Jennifer Wilkie/Adrian Howard 613-786-0156 representing Novartis Andrew Brodkin/Daniel Cappe 416-597-4278 representing Apotex Inc. Minutes of Hearing entered in Vol. 844 page(s) 451 - 457 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of John Norman confirming service of doc. 53 upon Plaintiff by personal service on 30-MAY-2011 filed on 30-MAY-2011
Acknowledgment of Receipt received from Novartis by telephone; Teva by email on May 30, 2011 with respect to doc.52 placed on file on 30-MAY-2011
Defence and Counterclaim on behalf of Novartis AG with consent to extend the time for filing filed on 30-MAY-2011
Order dated 30-MAY-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Letter from Plaintiff dated 26-MAY-2011 re: approving draft order resolving motion doc. 20 (Novartis' motion in T-2021-10 to stay the said action pending determination of T-679-11); motion doc. 23 (Teva's motion in T-2021-10 to stay T-679-11 until detrmination of the action in T-2021-10, or in the alternative that the 2 proceedings be consolidated); motion doc. 33 (Novartis AG's motion in T-2021-10 for consolidation of the evidentiary schedules in T-2021-10, T-679-11 and T-599-11); and Apotex's motion in T-599-11 made as part of its responding motion record to Motion doc. 33 for an Order consolidating T-2021-10 and Result: 1. Actions T-2021-10 and T-833-11 are consolidated and will be heard together, although pleadings will remain seperate. 2. If counterclaims to the actions are filed, they are not to be consolidated, but are to be heard by the same Judge, either simultaneously or consecutively, as he or she may direct. 3. The applications in T-599-11 and T-679-11 shall be heard by the same Jusge as the actions, either simultaneously or consecutively, as he or she may direct. 4. In determining the issues of whether the allegations of the Notices of Allegations are justifed will be dtermined on the basis of the evidence led at the trial of the actions, subject to the evidence's relevance for the purpose of the applications. 5. The manner in which evidence on all other issues in the applications is to be adduced is left to be detrmined at a later date. 6. The schedule set out for T-2021-10 applies to T-833-11. 7. In the applications, a response to the requests for 6(7) disclosures will have been provided by May 20, 2011. 8. In the applications, a response to the requests for 6(7) disclosures will have been provided by May 20, 2011. 8. In the applications, any motion for 6(7) disclosure will be scheduled at the May 31, 2011 telephone conference. 9. Novartis will serve and file its statements of defence and counterclaims to the actions no later than May 30, 2011. 10. A case management telephone conference will be held at 2p.m. on May 31, 2011. Filed on 30-MAY-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1125 page(s) 11 - 15 Interlocutory Decision
Letter from Plaintiff (Teva) dated 26-MAY-2011 I write on the agreement of counsel for all parties in the above matters to advise that the draft order prepared by the Court on May 16, 2011 has been approved by all parties. received on 26-MAY-2011
Letter from Defendant dated 25-MAY-2011 Pursuant to the agreement of parties May 16th, the Statement of Defence and Counterclaim is due May 25, 2011...new facts have come to light...the Defendant respectfully requests an extension of time until May 30, 2011 to srve and file its Statement of defence and Counterclaim. (scanned) received on 25-MAY-2011
Acknowledgment of Receipt received from Plaintiff with respect to fax confirmation of Order Doc.51 placed on file on 20-MAY-2011
Supplementary Order and Endorsement dated 20-MAY-2011 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 9 Result: 1) Paragraph 1(d) of the Statement of Claim is struck. 2) Costs of the motion are hereby fixed in the amount of $5,000 payable forthwith by Novartis to Teva. Filed on 20-MAY-2011 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1124 page(s) 200 - 207 Interlocutory Decision
Copy of Apotex's Responding Motion Record (Doc.18)in reply to motion doc. 20,23&33 dated 13-MAY-2011 To be heard on May 16, 2011 with T-2021-10 and T-679-11 placed on file on 13-MAY-2011 Original filed on Court File No. T-599-11
Written directions received from the Court: Mireille Tabib, Prothonotary dated 16-MAY-2011 directing that As counsel for the parties will be seeking their respective client's approval of the draft order proposed at today's hearing, the Court wishes to remind the parties that dates for a trial in T-2021-10 in September 2012 have been requested, but that the Court has not committed to such dates being available and does not yet know whether they will be. Any consent given by the parties to the proposed draft order should not therefore be dependant or contingent on the date(s) on which the trial is to be fixed. If the parties cannot give their consent without being certain of the dates to be fixed for trial, they are to advise the Court and each other as soon as possible." placed on file on 16-MAY-2011 Confirmed in writing to the party(ies)
Ottawa 16-MAY-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 20 on behalf of Novartis to stay T-2021-10 pending determination of T-679-11 Result of Hearing: Counsel discussed the motion, but did not argue the motion. Counsel are presenting a proposed order to their clients for for approval. Before the Court: Motion Doc. No. 23 on behalf of Teva Canada Ltd. to stay T-679-11 pending determination of T-2021-10; in the alternative, to consolidate T-679-11 with T-2021-10 Result of Hearing: Counsel discussed the motion, but did not argue the motion. Counsel are presenting a proposed order to their clients for approval. Before the Court: Motion Doc. No. 33 on behalf of Novartis to consolidate the evidentiary schedules in T-2021-10, T-679-11 and T-599-11 Result of Hearing: Counsel discussed the motion, but did not argue the motion. Counsel are presenting a proposed order to their clients for approval. held in Court Senior Usher: Brian Cooper Duration per day: 16-MAY-2011 from 09:30 to 03:00 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 5.5h Appearances: Jonathan Stainsby/Andrew Skodyn 416-360-3568 representing Teva Canada Ltd. John Norman/Jennifer Wilkie 613-783-8848 representing Novartis AG and Novartis Pharmaceuticals Andrew Brodkin/Daniel Cappe 416-597-4278 representing Apotex Inc. Comments: A new related action was filed May 13, 2011: T-833-11; Counsel drafted an agreement to propose to their clients which was provided to the Court; The Court re-drafted the agreement based on counsel's input and provided a draft copy to all parties to present to their clients for approval; Mr. Brodkin and Mr. Stainsby are to submit a reply to Novartis' request for a 67 motion for disclosure by May 20,2011; Any motion for disclosure shall be scheduled/ discussed at the CMC on May 31, 2011; The Statement of Defence and Counterclaim are to be served and filed by May 25, 2011; Reply deadline to be discussed at the next CMC on May 31, 2011. Heard together with T-679-11 and T-599-11//Minutes taken in T-2021-10 only. Minutes of Hearing entered in Vol. 843 page(s) 476 - 486 Abstract of Hearing placed on file
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 13-MAY-2011
Solicitor's certificate of service on behalf of John Norman confirming service of document 49 upon Plaintiff Respondent by hand on 13-MAY-2011 filed on 13-MAY-2011
Motion Record in response to Motion Doc. No. 23 containing the following original document(s): 48 Number of copies received: 3 on behalf of Defendant filed on 13-MAY-2011
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 23 filed on 13-MAY-2011
Solicitor's certificate of service on behalf of Andy Radhakant confirming service of document 46 upon Defendant Respondent Applicant by e-mail and hand on 13-MAY-2011 filed on 13-MAY-2011
Motion Record in response to Motion Doc. No. 20 containing the following original document(s): 44 45 Number of copies received: 3 on behalf of Plaintiff filed on 13-MAY-2011
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion docs. 20 & 33 filed on 13-MAY-2011
Affidavit of Alisha Schell sworn on 06-MAY-2011 contained within a Motion Record on behalf of Plaintiff in response to Motion docs. 20 & 33 with Exhibits A to D filed on 13-MAY-2011
Solicitor's certificate of service on behalf of Andrew Skodyn confirming service of Doc 42 upon Defendant by overnight courier on 13-MAY-2011 filed on 13-MAY-2011
Amended Statement of Claim filed on 13-MAY-2011
Acknowledgment of Receipt received from All parties with respect to doc.41 fax confirmation as per standing agreement placed on file on 11-MAY-2011
Order dated 10-MAY-2011 rendered by Kevin Aalto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 9 Result: dismissed If the parties are unable to agree on the disposition of costs, then each party may submit to the Court within 15 days of the date of this order a two page double-spaced written representation on the disposition of costs Filed on 10-MAY-2011 copies sent to parties entered in J. & O. Book, volume 1123 page(s) 169 - 171 Interlocutory Decision
Letter from Plaintiff dated 09-MAY-2011 requesting that an order in respect to the motion heard on March 29, 2011 be rendered as soon as possible. received on 09-MAY-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAY-2011 directing that Re: Novartis' motion filed May 5, 2011 (to consolidate the schedule) shall be briefed and heard as follows: 1) Teva is to serve on Apotex the affidavits in response to Novartis' previous motion (doc.20) in T-2021-10 by the end of the day. 2) Responding affidavits to be served by noon on May 10. 3) Cross-examinations to be held o later than May 12. 4) Parties have leave to file consolidated motion records on diverse motions and/or files into single records, as may be the most efficient, to be filed in T-2021-10 to avail for all. 5)Responding records to be filed in hard copy in Ottawa by 4:30p.m. on May 13, 2011 with electronic copies by 2:00p.m. on May 13, 2011. 6)Hearing in Ottawa on May 16, at 9:30a.m. for a full day. placed on file on 06-MAY-2011 Confirmed in writing to the party(ies)
Ottawa 06-MAY-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference To discuss the scheduling of the motion to stay in T-2021-10 (doc.20); the motion to stay T-679-11 or consolidate, filed in T-2021-10 (doc.23), and the motion to consolidate the evidentiary schedule in T-2021-10, T-679-11 and T-599-11, which was filed on T-2021-10 (doc.33). Result of Hearing: Hearing on May 16, 2011 will now commence at 9:30a.m. for 1 full day. Direction to follow. held in chambers by way of Conference Call Duration per day: 06-MAY-2011 from 01:25 to 01:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 20min Appearances: Jonathan Stainsby/Lesley Caswell 416-360-3568 representing Plaintiff (Teva) John Norman/Anthony Creber/Ms. Raasch 613-783-8848 representing Defendant(Novartis) Andrew Brodkin 416-597-4278 representing Respondent, Apotex Inc. in T-599-11 Comments: This CMC dealt with T-2120-10, T-679-11 and T-599-11. Minutes were only taken in T-2120-10. Minutes of Hearing entered in Vol. 843 page(s) 233 - 236 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of jOHN nORMAN confirming service of DOC.39 upon Teva, Apotex and the Minister of Health by personal service on 05-MAY-2011 filed on 05-MAY-2011
Motion Record containing the following original document(s): 33 36 37 38 Number of copies received: 3 on behalf of the defendant (Novartis AG) filed on 05-MAY-2011
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 33 filed on 05-MAY-2011
Affidavit of Dr. Peter Roth sworn on 05-MAY-2011 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 33 with Exhibits A filed on 05-MAY-2011
Affidavit of Erin McIntomny sworn on 04-MAY-2011 contained within a Motion Record on behalf of Defendant(T-2021-10); Respondent(T-599-11); Respondent (T-679-11) in support of Motion Doc. No. 33 with Exhibits A-G filed on 05-MAY-2011
Covering letter from Defendant dated 03-MAY-2011 concerning Affidavit of Dr. Peter Roth placed on file on 06-MAY-2011
Affidavit of service of Erin McIntomny sworn on 03-MAY-2011 on behalf of Defendant with consent to extend the time for filing confirming service of the Affidavit of Dr. Peter Roth (to be placed at Exhibit "S" of doc. 28) upon Plaintiff by telecopier on 03-MAY-2011 filed on 06-MAY-2011
Sworn Affidavit of Dr. Peter Roth (to be replaced at Exhibit "S" of the Affidavit of Erin McIntomny (Doc. 28)). See Directions of May 6, 2011. placed on file on 06-MAY-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAY-2011 directing that (Re: Communication to Court dated May 5, 2011) 1. In regards to the sworn affidavit of Peter Roth, submitted by Novartis to replace the unsworn copy at exhibit "S" of the Affidavit of Erin McIntomny (Doc. 28). The sworn copy was received on May 3, 2011. "Accept for filing, subject to any objection the opposing party may raise." placed on file on 06-MAY-2011 Confirmed in writing to the party(ies)
Letter from Apotex (VIA E-MAIL) in reply to the Direction of May 4, 2011 dated 05-MAY-2011 I am thus available at 1p.m. on May 6, 2011 should the Court wish to proceed as scheduled... received on 05-MAY-2011
Written directions received from the Court: Mireille Tabib, Prothonotary dated 05-MAY-2011 directing that "A case management telephone conference will be held on May 6, 2011 at 1p.m. placed on file on 05-MAY-2011 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 05-MAY-2011 re: Defendant submitted a "sworn" copy of Exhibit "S" of the affidavit of Erin McIntomny (doc.28) as original contained in doc. 30 was not sworn. Sent for directions. (Judge's copies of doc. 30 vol. 1 and 2 sent to Court without main file)
Written directions received from the Court: Mireille Tabib, Prothonotary dated 04-MAY-2011 directing that 1. In reply to Mr. Clarizio's letter (Apotex in T-599-11) dated May 3, 2011: "Apotex having requested, on April 26, 2011, a case managment conference "as soon as possible", declaring itself available "at the Court's convenience" but omitting to provide the Court with its opponent's availabilities, the Court acted accordingly in requesting Novartis' availabilities and fixing the date of May 6 in consequence. If Apotex is no longer available that date then Apotex is to provide the Court with both counsel's availabilities, and the Court will then fix the date for the telephone conference. The case management telephone conference scheduled for May 6, 2011 is adjourned." 2. In reply to Mr. Norman's letter of May 4 requesting leave to file 1 motion record (for a consolidated schedule) in T-2021-10 bearing all 3 styles of cause: "Leave is granted and the motion record may be filed as received, to avail for all three Court files." placed on file on 04-MAY-2011 Confirmed in writing to the party(ies)
Letter from Novartis dated 04-MAY-2011 requesting that the Court issue a direction to file their motion for a consolidated schedule in T-2021-10 bearing the styles of cause in T-2021-10, T-679-11 and T-599-11 and for the filing to be applied to the latter 2 files as well. received on 04-MAY-2011
Solicitor's certificate of service on behalf of John Norman confirming service of doc.33 upon Defendant (Teva) by telecopier on 03-MAY-2011 filed on 03-MAY-2011
Notice of Motion on behalf of the defendant, Novartis AG returnable at Special Sitting in Ottawa on 16-MAY-2011 to begin at 02:00 for an Order 1. Consolidating the evidentiary schedules of T-2021-10(Teva Action), T-599-11(Apotex Application) & T-679-11(Teva Application); and 2. In T-599-11 and T-679-11, if applicable, setting a schedule as follows: (a)Motions pursuant to s.6(7) of th Patented Medicines (NOC) Regs. to be brought by June 15/11; (b) Evidence related to allegations regarding validity made by the respondents (Apotex T-599-11 & Teva T-679-11), if applicable, and evidence of infringement of the Applicant Novartis to be served by December 21, 2011; (c) Evidence related to allegations regarding infringement made by the Respondents (Apotex in T-599-11/Teva in T-679-11), if applicable and evidence regarding validity of Applicant Novartis to be served by March 1/11; (d) cross-examinations to be conducted @ hearing/trial date to be set for T-2021-10; (e)written argumants to be provided within 2 weeks after the end of hearing/trial referred-to above;3) granting Novartis costs on the motion. filed on 03-MAY-2011
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Defendant's Book of Authorities re: Motion doc. 20 upon Plaintiff by courier on 03-MAY-2011 filed on 03-MAY-2011
Book of Authorities consisting of 1 volume(s) on behalf of Novartis AG in support of Motion Doc. 20 being heard May 16, 2011 received on 03-MAY-2011
Letter from Plaintiff (Teva) dated 03-MAY-2011 in response to the letter from Novartis dated May 2, 2011 in T-599-11. Counsel for Teva wishes to attend the CMC scheduled in T-599-11...at 1p.m. on May 6...(scanned) received on 03-MAY-2011
Copy of a Letter from Novartis in T-599-11 dated 02-MAY-2011 in response to Apotex's letter of April 26 and the Court's direction of the same date...Novartis believes that it would be prejudicial to consider any schedule in this proceesing before the issue of the stay is resolved in T-2021-10 and T-679-11...Novartis will be bringing a motion for a schedule whereby the schedule for evidence of the Apotex case will be consolidated with that of the Teva case(s)...we propose to file our notice of motion tomorrow and the remainder of the record by May 5, 2011. received on 02-MAY-2011
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc.30 upon Plaintiff by personal service on 29-APR-2011 filed on 29-APR-2011
Motion Record containing the following original document(s): 20 28 29 Number of copies received: 3 on behalf of Defendant (Novartis AG)/3 vol/doc. 20 filed 19-APR-11/Judge's copies in Y2 filed on 29-APR-2011
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 20 filed on 29-APR-2011
Affidavit of Erin McIntomny sworn on 29-APR-2011 contained within a Motion Record on behalf of defendant, Novartis AG in support of Motion Doc. No. 20 with Exhibits A-T filed on 29-APR-2011
Covering letter from Plaintiff dated 29-APR-2011 concerning Doc. No. 25 placed on file on 29-APR-2011
Solicitor's certificate of service on behalf of Andy Radhakant confirming service of doc. 26 and authorities upon Defendant ; Novartis Pharmaceuticals Cda. Inc. & The Minister of Health in T-679-11 by personal service on 29-APR-2011 filed on 29-APR-2011
Book of Authorities consisting of 2 volume(s) on behalf of Teva Canada in support of motion doc. 23 received on 29-APR-2011
Motion Record containing the following original document(s): 23 24 25 Number of copies received: 3 on behalf of the Plaintiff (Teva Canada) (Judge's copies in Y1) filed on 29-APR-2011
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 23 filed on 29-APR-2011
Affidavit of Ildiko Mehes sworn on 27-APR-2011 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 23 with Exhibits A-G filed on 29-APR-2011
Notice of Motion contained within a Motion Record on behalf of the Plaintiff (Teva Canada) returnable at Special Sitting in Ottawa on 16-MAY-2011 to begin at 02:00 for an Order pursuant to 50(1)(b) of the FC Act and/or 105(b) of the FC Rules staying the application in T-679-11 until the determination of action T-2021-10; In the alternative, an Order pursuant to 105(a) of the FC Rules that the application (T-679-11) and the action (T-2021-10) be consolidated; costs. filed on 29-APR-2011
Communication to the Court from the Registry dated 20-APR-2011 re: Letter from defendant dated April 20, 2011 sent to Court for consideration
Letter from Defendant dated 20-APR-2011 This is further to the recent correspondence from Teva in respect of Novartis' motion to strike and/or particulars that is currently under reserve. received on 20-APR-2011
Communication to the Court from the Registry dated 20-APR-2011 re: Letter from the Plaintiff dated April 20, 2011 sent to Prothonotary Aalto as requested
Letter from Plaintiff dated 20-APR-2011 Further to the letter of April 18, 2011... received on 20-APR-2011
Acceptance of Service received from all parties via e-mail on April 21, 2011 with respect to doc.22 placed on file on 21-APR-2011
Order dated 21-APR-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1) The defendant shall serve/file a full motion record for a stay by April 29/11. 2) Plaintiff serve/file full motion record to consolidate this action and T-679-11 by April 29/11. 3) Plaintiff has leave to file its motion bearing both styles of cause in T-2021-10 only to avail for Court T-679-11 as well. 4) Responding affidavits on the motion in par.1&2 shall be served by May 6/11. 5) Cross-examinations on affidavits held by May 11/11. 6) Responding motion records served/filed in Ottawa by 2p.m. (electronic or hard copy) before May 13/11. Hard copies may be filed in Ottawa by 4:30 on May 13 provided that an elctronic copy has been provided to the Court prior to 2p.m. on May 13/11. 7) Motions in paragraphs 1&2 will be heard at a special sitting in Ottawa at 2p.m. on May 16/11 for 2.5 hours. 8) A CMC will be held at 2p.m. on May 31/11 to finalize all aspects of the schedule for à proceeding in this matter, up to and including a trial on or about September 12, 2012. 9) In the meantime parties are to conduct themselves so as to meet the following deadlines: (see hard copy of Order for details) Filed on 21-APR-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1121 page(s) 274 - 277 Interlocutory Decision
Ottawa 19-APR-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A further case management conference will be held on May 31, 2011 at 2p.m. Order to issue. held in chambers by way of Conference Call Duration per day: 19-APR-2011 from 02:00 to 03:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1h20min Appearances: Mr. Jonathan Stainsby/Mr. Andrew Skodyn/Mr. Andrew McIntyre 416-360-3568 representing Plaintiff Mr. John Norman/Ms. Jennifer Wilkie 613-783-8848 representing Defendant Comments: Schedule established for the Defendant's Motion to stay (doc. 20) the within proceedings as well as the impending motion in T-679-11 to consolidate. Minutes of Hearing entered in Vol. 842 page(s) 320 - 327 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of John Norman confirming service of the Notice of Motion for stay upon Plaintiff by telecopier on 19-APR-2011 filed on 19-APR-2011
Notice of Motion on behalf of Defendant returnable (but no hearing date indicated at this time) for a staying of the action in T-2021-10 until after the resolution of application T-679-11 or until expiry of Canadian patent 2, 093, 203 on April 1, 2013, whichever is earlier filed on 19-APR-2011
Letter from Plaintiff dated 18-APR-2011 in relation to Motion heard on 29-MAR-2011 received on 18-APR-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-APR-2011 directing that "A case management telephone conference will be held on 19-APR-2011 at 2:00 p.m." Parties advised by e-mail. placed on file on 18-APR-2011
Letter from Plaintiff dated 18-APR-2011 in response to the Defendant's letter dated 15-APR-2011 received on 18-APR-2011
Communication to the Court from the Registry dated 18-APR-2011 re: Letters dated 15-APR-2011
Letter from Defendant dated 15-APR-2011 in response to the Directions dated 14-APR-2011, providing their availability for a case management conference and suggesting that related files be included for consideration of scheduling issues received on 18-APR-2011
Letter from Plaintiff dated 15-APR-2011 We write in response to the Court's direction dated April 14, 2011 to advise that counsel for Teva are available at any time between now and April 29 for a case conference in this action. received on 15-APR-2011
Proof of receipt (facsimile confirmation) received from all parties with respect to Directions dated 14-APR-2011 placed on file on 14-APR-2011
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-APR-2011 directing that "Both counsel shall, no later than 18-APR-2011, provide their dates of availability to participate in a case management telephone conference to discuss the scheduling of this matter, with a view to identifying and reserving potential trial dates." placed on file on 14-APR-2011 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 14-APR-2011 re: letter dated 14-APR-2011
Letter from Plaintiff dated 14-APR-2011 requesting a case management conference and providing a brief background of proceedings received on 14-APR-2011
Proof of Service of Fax received from All parties with respect to Doc. #19 (Order from CJL dated April 13, 2011). placed on file on 13-APR-2011
Order dated 12-APR-2011 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Order dated 15-MAR-2011 Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 13-APR-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1120 page(s) 473 - 473 Interlocutory Decision
Communication to the Court from the Registry dated 29-MAR-2011 re: Sent to Judicial Administrator to have a case management Judge assigned, pursuant to the Order dated March 15, 2011.
Ottawa 29-MAR-2011 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Motion Doc. No. 9 on behalf of Defendant Result of Hearing: Matter reserved held in Court Duration per day: 29-MAR-2011 from 10:00 to 01:45 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 3h45min Appearances: Andrew Skodyn/Andrew McIntyre 416-360-6336 representing Plaintiff John Norman/Adrian Howard 613-783-8848 representing Defendant Comments: Loose authorities were submitted by the Defendant Minutes of Hearing entered in Vol. 841 page(s) 39 - 48 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of Doc. no. 17 and plaintiff book of authorities upon Defendant by overnight courier on 25-MAR-2011 filed on 25-MAR-2011
Book of Authorities consisting of 2 volume(s) on behalf of Plaintiff received on 25-MAR-2011
Motion Record in response to Motion Doc. No. 9 containing the following original document(s): 15 16 Number of copies received: 3 on behalf of Plaintiff filed on 25-MAR-2011
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 9 filed on 25-MAR-2011
Affidavit of Alisha Schell sworn on 22-MAR-2011 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 9 with Exhibits A-F filed on 25-MAR-2011
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Book of Authorities of the Defendant upon Plaintiff by courier on 23-MAR-2011 filed on 23-MAR-2011
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 23-MAR-2011
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Motion Record of the Defendant upon Plaintiff by e-mail on consent on 18-MAR-2011 filed on 23-MAR-2011
Motion Record containing the following original document(s): 9 10 11 Number of copies received: 3 on behalf of Defendant filed on 23-MAR-2011
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 9 filed on 23-MAR-2011
Affidavit of Marcail Delahunt sworn on 18-MAR-2011 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 9 with Exhibits "A" to "H" filed on 23-MAR-2011
Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for (1) an Order pursuant to Rule 221(1)(a)(c) and (f) striking out paragraphs 1(c), 1(d), 6, 25-29, 38, 39 and 41 of the Statement of Claim issued December 3, 2010 without leave to amend; (2) an Order striking portions of paragraphs without leave to amend; (3) an Order for further and better particulars; (4) an Order extending the time for delivery of the Defence to 20 days after the disposition of this motion; (5) costs of this motion. filed on 23-MAR-2011
Acknowledgment of Receipt received from all parties (fax confirmation attached) with respect to doc. 8 placed on file on 16-MAR-2011
Order dated 15-MAR-2011 rendered by Martha Milczynski, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: "1. This action shall continue as a specially managed proceeding and is referred to the office of the Chief Justice for designation of a Case Management Judge. 2. The Defendant's motion is scheduled to be heard by Prothonotary Aalto at the Federal Court in Ottawa on Tuesday March 29, 2011 commencing at 10:00 a.m. 3. All materials for the motion shall be filed no later than Friday March 25, 2011. 4. The timetable for the balance of the steps, including the scheduling of any further motions, is referred to be fixed by the Case Management Judge." Filed on 16-MAR-2011 entered in J. & O. Book, volume 1117 page(s) 272 - 273 Interlocutory Decision
Toronto 15-MAR-2011 BEFORE Martha Milczynski, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: The Court directed that it will attempt to locate a member of the Court to hear the Respondent's motion to strike/particulars on March 23, 2011 in Ottawa held by way of Conference Call in chambers Duration per day: 15-MAR-2011 from 02:00 to 02:10 Courtroom : Judge's Chambers - Toronto Court Registrar: Natashia Bennett-Nelson 15-MAR-2011 from 02:30 to 02:33 Courtroom : Judge's Chambers - Toronto Court Registrar: Natashia Bennett-Nelson Total Duration: 13min Appearances: Mr. Jonathan Stainsby / Ms. Leslie Caswell / Mr. Andrew McIntyre (416) 360-3568 / (416) 643-6842 / (416) 786-0140 representing Applicant Mr. Anthony Creber (613) 786-0140 representing Respondent Comments: Upon consulting the office of the Trial Judicial Administrator, this Court reconvened briefly to advise the parties that nobody was available to hear the Respondent's motion on March 23, 2011. The Court apologized and sought further dates of the parties' availability. The dates provided were: March 24, 25, 29, 31 and the week of April 4, 2011. The Court agreed to canvass those dates to see if anyone would be available to hear the motion in Ottawa Minutes of Hearing entered in Vol. 839 page(s) 472 - 475 Abstract of Hearing placed on file
Oral directions received from the Court: Martha Milczynski, Prothonotary dated 09-MAR-2011 directing that a case management teleconference will be held on Tuesday, March 15, 2011 at 2:00 p.m. placed on file on 09-MAR-2011 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 09-MAR-2011 providing dates of availability for a case management teleconference (cc'd to D's counsel) received on 09-MAR-2011
Letter from Defendant dated 08-MAR-2011 in response to the Plaintiff's letter dated 7-MAR-2011 agreeing that the matter should proceed as a specially managed proceeding. received on 08-MAR-2011
Communication to the Court from the Registry dated 08-MAR-2011 re: P's letter dated 8-MAR-2011
Letter from Plaintiff dated 07-MAR-2011 requesting that this action proceed as a specially managed proceeding and that a case manager be appointed as soon as possible. Copy of DEMAND FOR PARTICULARS ATTACHED (cc'd to D's counsel) received on 07-MAR-2011
Affidavit of service of Alisha Schell sworn on 18-JAN-2011 on behalf of Plaintiff confirming service of Doc. 1 upon Defendant by courier on 22-DEC-2010 with Exhibits A filed on 18-JAN-2011
Tender of payment into Court on behalf of Plaintiff pursuant to Order filed on 17-DEC-2010 in the amount of $30,000.00 filed on 23-DEC-2010
Acknowledgment of Receipt received from Plaintiff with respect to Order DOC # 5, by way of fax confirmation sheet placed on file on 17-DEC-2010
Order dated 17-DEC-2010 rendered by Martha Milczynski, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 2 Result: granted - for security for costs ($30,000.00) - Filed on 17-DEC-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1109 page(s) 327 - 328 Interlocutory Decision
Letter from Plaintiff dated 10-DEC-2010 requesting that this motion in writing be dealt with as soon as possible such that an order may be obtained prior to the Christmas recess. In the alternative, if the Court wishes to hear oral submissions on the manner, counsel for Teva Canada is available to attend at General Sitting on 20-DEC-2010 received on 10-DEC-2010
Motion Record containing the following original document(s): 2 3 Number of copies received: 3 on behalf of Plaintiff filed on 10-DEC-2010
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 2 filed on 10-DEC-2010
Notice of Motion made ex parte contained within a Motion Record on behalf of Plaintiff in writing to be dealt with in the Toronto local office for an Order pursuant to section 60(3) of the Patent Act fixing secutiry for costs of the Defendant in the sum of thiry thousand dollars and other reliefs filed on 10-DEC-2010 Draft Order\\Judgment received.
Statement of Claim and 2 copies filed on 03-DEC-2010 Tariff other action - $150.00
The official version of the court proceeding information is available from the court websites directly: